{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01877", "age": 22, "sex": "Male", "country": "United States", "bmi": 40.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00430", "age": 52, "sex": "Female", "country": "United States", "bmi": 39.9, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00323", "age": 53, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02965", "age": 64, "sex": "Female", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00075_AGE", "age": 20, "sex": "Male", "country": "United States", "bmi": 38.6, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03489", "age": 6, "sex": "Male", "country": "United States", "bmi": 39.2, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01866_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.8, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01195_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.3, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01452_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01016_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02851_AGE", "age": 1, "sex": "Male", "country": "United States", "bmi": 39.1, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT07037459", "url": "https://clinicaltrials.gov/ct2/show/NCT07037459", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age = 18 years.-BMI = 30 kg/m^2.-HF diagnosed for at least 30 days before screening with New York Heart Association(NYHA) Class II-IV.-Managed with HF standard of care therapies.-Left ventricular ejection fraction (LVEF) of > 40%.-Elevated NT-proBNP.-Participants must have at least one of the following:1. Structural heart disease OR2. Documented hospitalization with a primary diagnosis of decompensated HF within12 months before randomization OR3. Evidence of elevated filling pressures within 12 months before randomization.Exclusion Criteria:-History of any of the following within 60 days before screening: Type I(spontaneous) MI, valvular replacement or repair, coronary revascularization,coronary artery bypass graft surgery or other major cardiovascular surgery, stroke.-HF due to: hypertrophic cardiomyopathy, infiltrative cardiomyopathy, activemyocarditis, constrictive pericarditis, cardiac tamponade, arrhythmogenic rightventricular or left ventricular cardiomyopathy/dysplasia, or uncorrected primaryvalvular heart disease, or clinically significant congenital heart disease.-Any lifetime history of LVEF = 40%.-Currently hospitalized with acute decompensated HF or hospitalization with a primarydiagnosis of decompensated HF within 30 days before screening.-Type 1 diabetes mellitus, or any type of diabetes with the exception of T2DM orhistory of gestational diabetes.-For participants with a prior diagnosis of T2DM at screening:1. HbA1c > 10.0%2. Uncontrolled diabetes requiring immediate therapy3. History of diabetic ketoacidosis or hyperosmolar state/coma4. One or more episodes of severe hypoglycemia within 6 months before screeningand/or history of hypoglycemia unawareness5. History of proliferative diabetic retinopathy, diabetic maculopathy, or severenon-proliferative diabetic retinopathy.-SBP = 180 mmHg , or on three or more blood pressure-lowering drugs with a SBP > 160mmHg.-History of chronic pancreatitis or acute pancreatitis in the 180 days beforescreening.-Family (or personal) history of medullary thyroid carcinoma or MEN-2.-eGFR < 20 mL/min/1.73 m^2 (CKD-EPI creatinine (Cr)-cystatin C equation) or receivingdialysis at screening.-Calcitonin = 50 ng/L (pg/mL) at screening.-Acute or chronic hepatitis.-Any of the following psychiatric history:1. History of unstable major depressive disorder or other severe psychiatricdisorder within 2 years before screening2. Lifetime history of suicide attempt3. History of non-suicidal self-injury within 5 years before screening.-History of any other condition that, in the opinion of the investigator, maypreclude the participant from following the protocol and completing the study.-Use of any glucagon-like peptide 1 receptor agonist (GLP-1 RA), glucose-dependentinsulinotropic polypeptide (GIP) agonists or antagonists, or amylin analogs within90 days before randomization or planned use during the conduct of the study.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02251", "age": 41, "sex": "Female", "country": "United States", "bmi": 33.0, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01460", "age": 28, "sex": "Male", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03200_AGE", "age": 19, "sex": "Female", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01212_AGE", "age": 29, "sex": "Female", "country": "United States", "bmi": 31.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02896", "age": 60, "sex": "Male", "country": "United States", "bmi": 41.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01787_BMI", "age": 63, "sex": "Male", "country": "United States", "bmi": 49.5, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02204_BMI", "age": 33, "sex": "Male", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00101", "age": 17, "sex": "Male", "country": "United States", "bmi": 45.0, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02358", "age": 7, "sex": "Male", "country": "United States", "bmi": 33.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01632_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 30.7, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00838_AGE", "age": 14, "sex": "Male", "country": "United States", "bmi": 44.6, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00629", "age": 11, "sex": "Female", "country": "United States", "bmi": 36.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03215_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03366_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.6, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00475_AGE", "age": 10, "sex": "Female", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06993792", "url": "https://clinicaltrials.gov/ct2/show/NCT06993792", "status": "Recruiting", "countries": ["United States", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "Argentina", "China", "Czechia", "Germany", "India", "Japan", "Mexico", "Puerto Rico", "United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "There are no specific eligibility criteria for the Master Protocol.-See study GZP1 for eligibility criteria relevant to participants with obesity andoverweight without type 2 diabetes-See study GZP2 for eligibility criteria relevant to participants with type 2diabetes", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02236", "age": 50, "sex": "Female", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01343", "age": 63, "sex": "Male", "country": "United States", "bmi": 34.2, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02413_BMI", "age": 68, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02691", "age": 59, "sex": "Male", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02735", "age": 66, "sex": "Male", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03244", "age": 56, "sex": "Male", "country": "United States", "bmi": 44.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00324_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 33.2, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-75"], "rationale": "Failed criteria: Age not in range 50-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03600", "age": 38, "sex": "Female", "country": "United States", "bmi": 36.8, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-75"], "rationale": "Failed criteria: Age not in range 50-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00471", "age": 35, "sex": "Female", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-75"], "rationale": "Failed criteria: Age not in range 50-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01181_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-75"], "rationale": "Failed criteria: Age not in range 50-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00277", "age": 24, "sex": "Male", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06949280", "url": "https://clinicaltrials.gov/ct2/show/NCT06949280", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and postmenopausal women (>2 years since last menses), ages 50-75 years-Body mass index (25-42 kg/m2) or evidence of pre-clinical obesity.-Agree to be randomly assigned to consume a daily peanut snack or nut-free snack for24 weeks-Must attend on-site visits (about 10) in New Brunswick, NJ, USA(transportation/reimbursement for travel not included)Exclusion Criteria:-Peanut allergies or intolerances-Participants with >5% weight loss in the past 6 months or extreme dietary/physicalactivity habits-An inability to follow the experimental intervention or to perform the requiredspecimen collections.-Individuals with significant psychiatric or food disorders.-Current diagnosis, or history of cancer in past 3 years.-Current diagnosis or history of bone diseases, type I or II diabetes,gastrointestinal disease, hyperparathyroidism, untreated thyroid disease,significant immune, hepatic, cardiac, or renal disease.-Uncontrolled hypertension or hyperlipidemia in abnormal ranges.-History of surgery in the past 6 months or surgical procedure for weight loss in thepast 3 years.-Regular use of medications that affect bone metabolism, including bisphosphonates orhormone replacement.-Regular use of medications for that affect the gastrointestinal tract includingincretin mimetics, cholecystitis, urinary tract infection, severe organic diseasesincluding coronary heart disease, myocardial infarction, infectious diseasesincluding pulmonary tuberculosis and AIDS.-Antibiotic use in the past month-Alcohol or illicit drug abuse-Any other condition deemed by the Research Physician that would preventparticipation in the study, e.g. participation in another clinical research projectthat may interfere with the results of this study.-Participation in another clinical interventional research trial", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-75"], "rationale": "Failed criteria: Age not in range 50-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01846", "age": 51, "sex": "Male", "country": "United States", "bmi": 24.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 18.5 and 24.9"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00066_BMI", "age": 24, "sex": "Female", "country": "United States", "bmi": 24.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 18.5 and 24.9"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02387_BMI", "age": 27, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 18.5 and 24.9"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02351_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 38.0, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-79", "BMI not in range 18.5-24.9"], "rationale": "Failed criteria: Age not in range 18-79, BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00784_BMI", "age": 45, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 79"], "failed_criteria": ["BMI not in range 18.5-24.9"], "rationale": "Failed criteria: BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01810", "age": 53, "sex": "Female", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 79"], "failed_criteria": ["BMI not in range 18.5-24.9"], "rationale": "Failed criteria: BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00933", "age": 65, "sex": "Female", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 79"], "failed_criteria": ["BMI not in range 18.5-24.9"], "rationale": "Failed criteria: BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02744_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.2, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-79", "BMI not in range 18.5-24.9"], "rationale": "Failed criteria: Age not in range 18-79, BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03340_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.0, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-79", "BMI not in range 18.5-24.9"], "rationale": "Failed criteria: Age not in range 18-79, BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00583_AGE", "age": 2, "sex": "Male", "country": "United States", "bmi": 40.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-79", "BMI not in range 18.5-24.9"], "rationale": "Failed criteria: Age not in range 18-79, BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03226", "age": 24, "sex": "Male", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 79"], "failed_criteria": ["BMI not in range 18.5-24.9"], "rationale": "Failed criteria: BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00568_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 39.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06970457", "url": "https://clinicaltrials.gov/ct2/show/NCT06970457", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 18.5, "bmi_max": 24.9, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Biological male-BMI 18.5 - 24.9 kg/m2 or >/= 30 kg/m2-Body fat <20% or >/= 25%-Ability and willingness to engage in an exercise training regimenExclusion Criteria:-Presence of a chronic health condition, or regular use of associate prescribedmedications, that would substantially impact study variables-Excessive alcohol use or use of tobacco products, vape products, or illicit drugs-Presence of an electrical implant, such as a pacemaker", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-79", "BMI not in range 18.5-24.9"], "rationale": "Failed criteria: Age not in range 18-79, BMI not in range 18.5-24.9", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00987", "age": 50, "sex": "Female", "country": "United States", "bmi": 40.7, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00724", "age": 29, "sex": "Female", "country": "United States", "bmi": 35.4, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02452", "age": 25, "sex": "Female", "country": "United States", "bmi": 33.0, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00814_BMI", "age": 70, "sex": "Male", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02756", "age": 68, "sex": "Male", "country": "United States", "bmi": 41.4, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03248", "age": 40, "sex": "Female", "country": "United States", "bmi": 38.8, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02289", "age": 20, "sex": "Male", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02755_BMI", "age": 29, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00061", "age": 28, "sex": "Female", "country": "United States", "bmi": 32.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01467_BMI", "age": 28, "sex": "Female", "country": "United States", "bmi": 26.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02031_AGE", "age": 9, "sex": "Male", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01278_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.1, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00191_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00733_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 38.7, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02054_AGE", "age": 15, "sex": "Female", "country": "United States", "bmi": 38.7, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03287_BMI", "age": 17, "sex": "Male", "country": "United States", "bmi": 84.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00834_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 42.9, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06875622", "url": "https://clinicaltrials.gov/ct2/show/NCT06875622", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index between 25-45 kg/m2-Daily, home Internet accessExclusion Criteria:-Currently pregnant, planning to become pregnant within the next 18 months, orpregnant within the past 6 months-Current or recent enrollment (<2 years) in a weight loss program-Presence of any medical condition for which exercise, weight loss, or dietaryrestriction is contraindicated-Recent weight loss (=10 pounds within the past 6 months)-Currently taking weight loss medications or history of bariatric surgery-Inability to walk 2 blocks without stopping-Non-English speaking-A member of one's household is participating in the study-History of anorexia or bulimia nervosa", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01564", "age": 14, "sex": "Female", "country": "United States", "bmi": 32.2, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 13 and 19", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01331_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 32.1, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 13 and 19", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01504_BMI", "age": 13, "sex": "Male", "country": "United States", "bmi": 18.5, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 13 and 19", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02803_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 13 and 19", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03470_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 13 and 19", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01378_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 13 and 19", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03063_BMI", "age": 44, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01393", "age": 53, "sex": "Male", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02913_AGE", "age": 8, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00482_AGE", "age": 21, "sex": "Male", "country": "United States", "bmi": 35.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01139", "age": 47, "sex": "Female", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00702_BMI", "age": 70, "sex": "Female", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01806_AGE", "age": 24, "sex": "Male", "country": "United States", "bmi": 40.0, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00925_BMI", "age": 51, "sex": "Male", "country": "United States", "bmi": 28.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06819813", "url": "https://clinicaltrials.gov/ct2/show/NCT06819813", "status": "Recruiting", "countries": ["United States"], "age_min": 13, "age_max": 19, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI=75th percentile for their age and sex-Report recent loss of control eating and/or overeating (=3 episodes of either typeof eating behavior in the past 3 months)-Have an email address, Smartphone, and regular access to the internet-Be willing and able to measure their height and weight prior to study enrollmentExclusion Criteria:-Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives,vomiting, driven exercise) in the past 3 months-Not fluent in English at a third-grade reading level or higher-Currently taking medications known to affect weight or appetite or concurrentlyinvolved in treatment for eating or weight disorders-Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimianervosa) known to significantly affect eating or weight, aside from binge eatingdisorder-Developmental or cognitive delay precluding participation in the intervention-Currently pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 13-19"], "rationale": "Failed criteria: Age not in range 13-19", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00143", "age": 42, "sex": "Male", "country": "United States", "bmi": 27.9, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00181", "age": 36, "sex": "Female", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01310", "age": 26, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02605", "age": 39, "sex": "Male", "country": "United States", "bmi": 20.1, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02051", "age": 39, "sex": "Female", "country": "United States", "bmi": 37.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03104", "age": 18, "sex": "Female", "country": "United States", "bmi": 42.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00408_AGE", "age": 18, "sex": "Male", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00036_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.5, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00511_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00650_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 39.7, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02267_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00182_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00464_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02609", "age": 16, "sex": "Female", "country": "United States", "bmi": 44.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00881_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01720_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06802861", "url": "https://clinicaltrials.gov/ct2/show/NCT06802861", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Recommended aspirin for pre-eclampsia prevention by OB/GYN or MFM specialist basedon ACOG and USPSTF guidelines (1 high risk factor, 2+ moderate risk factors)-Willingness to adhere to aspirin therapy-Willingness to undergo 2h OGTT for serum and urine collection in addition tosurvey collection, indirect calorimetry, body composition measures, neonatalmeasures, etc.-Gestational age at enrollment <16 weeks-Ability to speak, read, and communicate via EnglishExclusion Criteria:-Type 2 Diabetes Mellitus-Type 1 Diabetes Mellitus-Current gestational diabetes mellitus-Current/active platelet disorder or bleeding diathesis (thrombocytopenia of anyetiology, idiopathic thrombocytopenic purpura/ITP, thrombotic thrombocytopenicpurpura/TTP, von Willebrand disease, etc.)-Thrombophilia-Current use of NSAID for other indication (indomethacin, ibuprofen, etc.)-Current use of other immune-modulating agents and biologics(hydroxychloroquine, azathioprine, 6-mercaptopurine, IL-6 inhibitors, etc.)-Current or recent use of steroids-Current use of prophylactic or therapeutic anticoagulation-Medical contraindication to aspirin therapy-Molar pregnancy-Renal disease-Inability or unwillingness to give informed consent-Current psychiatric illness/social situation that would limit compliance withstudy requirements, as determined by the principal investigators", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-45"], "rationale": "Failed criteria: Age not in range 18-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01741", "age": 59, "sex": "Male", "country": "United States", "bmi": 29.0, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01854", "age": 24, "sex": "Female", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00182", "age": 22, "sex": "Male", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01763", "age": 20, "sex": "Male", "country": "United States", "bmi": 31.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02204", "age": 33, "sex": "Male", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02726_AGE", "age": 21, "sex": "Female", "country": "United States", "bmi": 41.7, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00681_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 33.7, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03379", "age": 13, "sex": "Female", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02801_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03214_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.7, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02943_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 36.7, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03266_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 37.3, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06785064", "url": "https://clinicaltrials.gov/ct2/show/NCT06785064", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age >18 years-Body mass index (BMI) >30 kg/m2-Has regular access to internet (to access Zoom videoconferencing platform)-If indicated during screening, willing to obtain medical clearance for exercise fromtheir healthcare provider prior to enrollmentExclusion Criteria:-Current or recent (past 6 months) use of prescription weight loss medications-Weight loss >10 pounds in past 6 months (other than postpartum)-Pregnancy or anticipating pregnancy-Another household member already participating in the study-Participation in another randomized research project-Uncontrolled hypertension (blood pressure >160/100 mm Hg at screening)-Any of the following other medical conditions: myocardial infarction orcerebrovascular accident within the last 6 months; unstable angina within the past 6months; NYHA Class III or IV congestive heart failure; type 1 diabetes; and chroniclung diseases that limit physical activity-Unable to identify potential buddy (i.e., adult friend or family member) forextended care intervention phase-Residing >50 miles from the university (to attend assessment visits)-Planning to relocate out of the area in the next 18 months-Does not have internet access-Unwilling or unable to do any of the following: give informed consent;read/understand English; accept random assignment", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00813_BMI", "age": 35, "sex": "Female", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01849", "age": 32, "sex": "Male", "country": "United States", "bmi": 19.4, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02084", "age": 24, "sex": "Male", "country": "United States", "bmi": 38.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01606_BMI", "age": 48, "sex": "Male", "country": "United States", "bmi": 19.5, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03200_AGE", "age": 19, "sex": "Female", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00888", "age": 30, "sex": "Female", "country": "United States", "bmi": 39.0, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03508", "age": 51, "sex": "Female", "country": "United States", "bmi": 31.6, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02474", "age": 33, "sex": "Female", "country": "United States", "bmi": 43.0, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01753", "age": 20, "sex": "Female", "country": "United States", "bmi": 34.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02406", "age": 48, "sex": "Male", "country": "United States", "bmi": 44.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03203", "age": 69, "sex": "Female", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01421_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 30.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01339", "age": 70, "sex": "Female", "country": "United States", "bmi": 40.6, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01567_BMI", "age": 69, "sex": "Female", "country": "United States", "bmi": 21.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00173_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.7, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03125_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03179", "age": 70, "sex": "Male", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00578_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01016_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06804603", "url": "https://clinicaltrials.gov/ct2/show/NCT06804603", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body Mass Index 25-40 kg/m^2 inclusive-No serious medical problems or chronic diseases, specifically no type I or type IIdiabetesExclusion Criteria:-Another disorder that contributes to gastrointestinal symptoms-History of intolerance and/or hypersensitivity to NK-1 receptor antagonists-History of intolerance and/or hypersensitivity to GLP-1 receptor agonists-Exposure to any investigational medication within the past 60 days", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01423", "age": 29, "sex": "Female", "country": "United States", "bmi": 32.0, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02841", "age": 23, "sex": "Female", "country": "United States", "bmi": 41.1, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00601", "age": 45, "sex": "Female", "country": "United States", "bmi": 31.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00001", "age": 50, "sex": "Male", "country": "United States", "bmi": 43.4, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01005", "age": 40, "sex": "Female", "country": "United States", "bmi": 34.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01051_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02006_AGE", "age": 19, "sex": "Male", "country": "United States", "bmi": 40.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01135_AGE", "age": 20, "sex": "Male", "country": "United States", "bmi": 38.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03359", "age": 10, "sex": "Female", "country": "United States", "bmi": 40.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01687_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03496_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06734312", "url": "https://clinicaltrials.gov/ct2/show/NCT06734312", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subjects aged 21-652. Body mass Index (BMI) =30 kilograms per square meter (kg/m), or =45 kg/m3. Observed = 10% TBWL with semaglutide or tirzepatide use for primary obesity therapy4. Subject did not experience >50% weight recurrence since discontinuation ofsemaglutide or tirzepatide5. Maintained a stable dose of semaglutide or tirzepatide for a minimum of 12 weeks6. Have recently discontinued or are planning to discontinue semaglutide or tirzepatide(= 24 weeks from last dose to time of study procedure)7. No previous medical history of diabetes mellitus8. Willing and able to participate in the study procedures9. Understand and voluntarily sign the informed consentExclusion Criteria:1. Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time ofscreening2. Use of GLP-1 or GLP-1/GIP medication for the treatment of diabetes, rather thanobesity.3. Use of anticoagulation, antithrombotic agents, and/or NSAIDs that cannot bediscontinued for a minimum of 12 weeks4. Known bleeding diathesis that cannot be corrected through medical means.5. History of decompensated end-organ disease6. Unwillingness to abstain from the use of incretin mimetics during the studyduration.7. Unwillingness to abstain from the use of tobacco during the study duration8. Patients on any medications or supplements including those that may influencecholecystokinin (CCK), glucose, growth hormone, insulin and/or somatostatin levels9. History of any stomach manipulation (including repair of hiatal hernia orfundoplication) deemed unsafe by PI for GFMA 10. Active disordered eating 11. Patients who do not give their consent to the enrollment in the study or areincompetent, unconscious or unable to express their consent for any reason 12. Known diagnosis of gastroparesis or functional dyspepsia 13. Patients who are pregnant, who plan to become pregnant during study duration, orpatients of child-bearing potential who refuse effective birth control methods (asapproved by PI) 14. Active H. pylori infection or history of H pylori without treatment and confirmationof eradication 15. Active gastric ulceration. 16. Use of concomitant medications known to induce weight loss (including but notlimited to liraglutide, phentermine, phentermine/topiramate, bupropion/naltrexone,metformin)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00801", "age": 48, "sex": "Male", "country": "United States", "bmi": 35.7, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01774", "age": 21, "sex": "Female", "country": "United States", "bmi": 32.3, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03110_BMI", "age": 19, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01472_BMI", "age": 32, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01567", "age": 69, "sex": "Female", "country": "United States", "bmi": 43.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02706_AGE", "age": 10, "sex": "Male", "country": "United States", "bmi": 41.5, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01170_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01327_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02507_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 37.9, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02093_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 25.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01321_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.0, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06645470", "url": "https://clinicaltrials.gov/ct2/show/NCT06645470", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Both males and females of all race/ethnic groups are eligible for participation inthis study.-Age: Randomized Study: Adults that are 18 to <60 years of age. Observational Study:Adults that are >60 years of age.-Newly prescribed AOM (semaglutide, tirzepatide) for the treatment of obesity,approval for treatment (pharmacy, insurance, etc.), and the participant agreeing tostart this treatment and continue treatment for at least 6 months (the participantwill be recruited prior to this medication being initiated).-Body mass index (BMI) of >27.0 kg/m2 with at least one weight-related complication(hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)provided it this does not compromise the ability to safely complete the screening oroutcome measures or to engage in the prescribed exercise interventions), or >30kg/m2 without weight-related complications. Enrollment will not be limited based onan upper BMI level provided that the participant meets the other eligibilityrequirements. However, weight or size limits of the dual-energy x-ray absorptiometry(DXA) system that is used to assess body composition must not be exceeded.-Ability to provide informed consent prior to participation in this study.-Clearance from the study physician for meeting all eligibility criteria for thisstudy.Exclusion Criteria:-Type 2 diabetes.-Report moderate-to-vigorous exercise for >60 min/week, and >1 day of structuredcardiovascular or resistance exercise over the past 3 months.-Report sustained weight loss of >3% in the past 3 months.-History of metabolic/bariatric surgery.-Females who are pregnant, pregnant within the past 6 months, or reporting a plannedpregnancy during the study period.-Report a current medical condition or treatment for a medical condition that couldaffect body weight or contradict engagement in any aspect of the outcome measures orinterventions.-History of muscle conditions that may impact the quality of muscle or response tothe study interventions (e.g., myopathy, muscular dystrophy, rhabdomyolysis, etc.).-Current congestive heart failure, angina, uncontrolled arrhythmia, symptomsindicative of an increased acute risk for a cardiovascular event, prior myocardialinfarction or history of cardiomyopathy, coronary artery bypass grafting orangioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrentDVT).-Resting systolic blood pressure of >160 mmHg or resting diastolic blood pressure of>100 mmHg. If medicated for blood pressure control, the medication dose needs to bestable for >6 months.-Eating disorders that would contraindicate weight loss or physical activity.-Alcohol or substance abuse.-Current psychological condition that is untreated, hospitalization for apsychological condition within the past 12 months, or not being on a stable dose oftreatment for at least 6 months.-Report plans to relocate to a location not accessible to the study site or havingemployment, personal, or travel commitments that prohibit attendance at scheduledintervention sessions or assessments.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01748_BMI", "age": 43, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02380", "age": 27, "sex": "Male", "country": "United States", "bmi": 36.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02728_AGE", "age": 21, "sex": "Male", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00362", "age": 32, "sex": "Male", "country": "United States", "bmi": 43.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00973", "age": 18, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01947", "age": 42, "sex": "Male", "country": "United States", "bmi": 40.3, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03484", "age": 47, "sex": "Male", "country": "United States", "bmi": 39.6, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02130", "age": 29, "sex": "Female", "country": "United States", "bmi": 32.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 79", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00615_BMI", "age": 53, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 79"], "failed_criteria": ["BMI not in range 25.0-100"], "rationale": "Failed criteria: BMI not in range 25.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03043_AGE", "age": 5, "sex": "Male", "country": "United States", "bmi": 43.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02032_AGE", "age": 9, "sex": "Male", "country": "United States", "bmi": 37.4, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00112_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00610_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00331_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 41.4, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00393_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00163_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 23.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-79", "BMI not in range 25.0-100"], "rationale": "Failed criteria: Age not in range 18-79, BMI not in range 25.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00746_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00739_AGE", "age": 6, "sex": "Male", "country": "United States", "bmi": 30.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06626113", "url": "https://clinicaltrials.gov/ct2/show/NCT06626113", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 79, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:1. Obese: BMI >25 m/kg22. Elevated insulin resistance: HOMA-IR > 2.5 (calculation based on fasting glucose andinsulin concentrations in blood)3. Middle-aged: 35-65 years4. Participants must be willing and able to discontinue taking any vitamin C or Esupplements or omega-3 fatty acids beginning 2 weeks prior.5. Able and willing to provide written informed consentExclusion criteria:1. Currently taking a statin or antihypertension medication2. Hyperlipidemia: Fasting triglycerides < 250 mg/dL3. Hypertension: >130/80 mmHg4. History of heart disease (e.g., myocardial infarction, stent)5. History of vascular disease (e.g., bypass, stroke)6. Individuals with narrow angle glaucoma-", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-79"], "rationale": "Failed criteria: Age not in range 18-79", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03523_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 33.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00415_BMI", "age": 14, "sex": "Female", "country": "United States", "bmi": 17.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02028_BMI", "age": 9, "sex": "Female", "country": "United States", "bmi": 0.7, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02759_AGE", "age": 9, "sex": "Female", "country": "United States", "bmi": 41.4, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03447", "age": 11, "sex": "Female", "country": "United States", "bmi": 35.6, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00834_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 42.9, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01936_AGE", "age": 7, "sex": "Male", "country": "United States", "bmi": 44.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00709", "age": 9, "sex": "Male", "country": "United States", "bmi": 43.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 14", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02557", "age": 54, "sex": "Male", "country": "United States", "bmi": 30.7, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-14"], "rationale": "Failed criteria: Age not in range 6-14", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02059_BMI", "age": 58, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-14"], "rationale": "Failed criteria: Age not in range 6-14", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00878", "age": 25, "sex": "Female", "country": "United States", "bmi": 36.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-14"], "rationale": "Failed criteria: Age not in range 6-14", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03536_AGE", "age": 22, "sex": "Female", "country": "United States", "bmi": 38.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-14"], "rationale": "Failed criteria: Age not in range 6-14", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00823_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 33.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06595251", "url": "https://clinicaltrials.gov/ct2/show/NCT06595251", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 14, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:\r\n\r\n-All participants enrolled in the Miami-Dade Fit2Play study will be included in this\r\nsecondary analysis\r\n\r\nExclusion Criteria:\r\n\r\n-Anyone not enrolled in the Miami-Dade Fit2Play study will be excluded from this\r\nsecondary analysis", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-14"], "rationale": "Failed criteria: Age not in range 6-14", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01667_AGE", "age": 49, "sex": "Male", "country": "United States", "bmi": 39.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01888", "age": 50, "sex": "Male", "country": "United States", "bmi": 38.6, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00514", "age": 63, "sex": "Female", "country": "United States", "bmi": 38.2, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00138", "age": 51, "sex": "Female", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01872_BMI", "age": 42, "sex": "Male", "country": "United States", "bmi": 96.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02563", "age": 34, "sex": "Male", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00364", "age": 47, "sex": "Female", "country": "United States", "bmi": 33.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03385", "age": 33, "sex": "Female", "country": "United States", "bmi": 32.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00680", "age": 67, "sex": "Male", "country": "United States", "bmi": 44.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02077_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02722_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00125_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03269", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06592261", "url": "https://clinicaltrials.gov/ct2/show/NCT06592261", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Body mass index of 18-25 and 30-45 kg/m2-Able to understand written and spoken English and/or Spanish-Fasting euinsulinemia (fasting serum insulin of 5-10 U/mL) for reference group orhyperinsulinemia (fasting serum insulin = 13 U/mL) for hyperinsulinemic group onscreening labs-Written informed consent (in English or Spanish) and any locally requiredauthorization (e.g., Health Insurance Portability and Accountability Act) obtainedfrom the participant prior to performing any protocol-related procedures, includingscreening evaluations.Exclusion Criteria:-Unable to provide informed consent in English or Spanish-Unwillingness to use only bedpan or urinal to void or to refrain from non-emergentmobile device use during the GIST-Documented weight loss of = 5% of baseline within the previous 6 months-Systolic blood pressure < 90 mm Hg or > 160 mm Hg, and/or-Diastolic blood pressure < 60 mm Hg or > 100 mm Hg-Abnormal resting heart rate: < 60 or = 110 bpm-Sinus brady or tachycardia that has been worked up and considered benign by therecruit's personal physician may be permitted at the PI's discretion-Abnormal screening electrocardiogram (or if on file, performed within previous 90d):-Non-sinus rhythm-Heart conduction blocks-Previously unknown ischaemic changes that persist on repeat EKG:-ST elevations-T-wave inversions in a vascular distribution-Hemoglobin A1c = 5.7%, and/or-Fasting plasma glucose = 100 mg/dL-Positive qualitative -hCG (i.e., pregnancy test) in women of childbearing potential-Positive urine drug screen, except for lawfully prescribed medications and/ormarijuana, provided that participant agrees to refrain from marijuana use during theperiod that they refrain from alcohol.-Transaminases (AST or ALT) > 3.0 x the upper limit of normal-Total bilirubin > 1.25 x the upper limit of normal-Abnormal sodium, potassium, chloride, or bicarbonate levels that are consideredpotentially significant according to the clinical judgment of the PI.-Creatinine equating to estimated glomerular filtration rate < 60 mL min-1 1.73 m-2-Hemoglobin < 10 g/dL or hematocrit < 30%-Platelet count < 100,000/L-Women currently pregnant, measured by serum and/or urine -hCG-Women currently breastfeeding-History of having met any of the American Diabetes Association's definitions ofprediabetic state or diabetes mellitus (i.e., overt diabetes):-Hemoglobin A1c = 5.7%, or rapid rise in documented HbA1c values causingclinical concern for evolving insulin deficiency-Plasma glucose = 100 mg/dL after 8-h fast-Plasma glucose of = 140 mg/dL at 2 h after ingestion of a 75-g glucose load-Random plasma glucose = 200 mg/dL associated with typical hyperglycemicsymptoms, diabetic ketoacidosis, or hyperglycemic-hyperosmolar state-History of gestational diabetes mellitus within the previous 5 years-Use of most antidiabetic medications within the 30 days prior to screening-Excluded: thiazolidinediones, sulfonylureas, meglitinides, DPP4 inhibitors,GLP-1 receptor agonists, SGLT2 inhibitors, amylin mimetics, acarbose, insulin-Metformin is acceptable provided that recruits meet all of the inclusioncriteria at screening-Known, documented history, at the time of screening, of any of the following medicalconditions:-Pancreatic pathology, including but not limited to: Pancreatic neoplasia(unless appropriately evaluated and considered benign and not producinghormones), Chronic pancreatitis, History of acute pancreatitis within the past5 years-Cardiovascular diseases (N.B. uncomplicated hypertension is not exclusionary)-Atherosclerotic cardiovascular disease-Stable or unstable angina-Myocardial infarction-Ischaemic or hemorrhagic stroke-Peripheral arterial disease (claudication)-Use of dual antiplatelet therapy (aspirin + P2Y12 inhibitor)-History of percutaneous coronary intervention-Heart rhythm abnormalities (non-sinus)-Congestive heart failure of any New York Heart Association class-Severe valvular heart disease (e.g., aortic stenosis)-Pulmonary hypertension-Chronic kidney disease, Stage 3 or higher (estimated glomerular filtration rate < 60mL/min/1.73 m2), of any cause-Advanced or severe liver disease, including but not limited to:-Advanced liver fibrosis, as determined by non-invasive testing-Cirrhosis of any etiology-Autoimmune hepatitis or other rheumatologic disorder affecting the liver-Biliopathy (e.g., progressive sclerosing cholangitis, primary biliarycholangitis)-Hepatocellular carcinoma-Infiltrative disorders (e.g., sarcoidosis, hemochromatosis, Wilson disease)-Gallstone disease, including:-Biliary colic (active)-History of acute cholecystitis not treated with cholecystectomy-History of other gallstone complications (e.g., pancreatitis, cholangitis)-Chronic viral illness (N.B. diagnosis based only on medical history and not bylaboratory confirmation)-Hepatitis B virus (HBV), unless previously successfully eradicated with antiviraldrugs that have been discontinued for at least 30 d prior to screening-Hepatitis C virus (HCV) infection, unless previously successfully eradicated withantiviral drugs that have been discontinued for at least 30 d prior to screening-Human immunodeficiency virus (HIV) infection-Active seizure disorder (including controlled with antiepileptic drugs)-Psychiatric diseases causing functional impairment that:-Are or have been decompensated within 1 year of screening, and/or-Require use of anti-dopaminergic antipsychotic drugs associated withsignificant weight gain/metabolic dysfunction (e.g., clozapine, olanzapine),monoamine oxidase inhibitors, tricyclic antidepressants, or lithium-Other endocrinopathies:-Cushing syndrome (okay if considered in remission after treatment, providedthat no exogenous corticosteroids or other ongoing treatment are required)-Adrenal insufficiency-Primary aldosteronism-Venous thromboembolic disease (deep vein thrombosis or pulmonary embolism) or anyrequired use of therapeutic anticoagulation-Bleeding disorders, including due to anticoagulation, or significant anemia-Active malignancy, or hormonally active benign neoplasm, except allowances for:-Non-melanoma skin cancer-Differentiated thyroid cancer (AJCC Stage I only)-Clinical concern for increased risk of volume overload, including due to medicationsand/or heart/liver/kidney problems, as listed", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01314", "age": 35, "sex": "Male", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02382", "age": 42, "sex": "Male", "country": "United States", "bmi": 43.0, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01000_AGE", "age": 24, "sex": "Female", "country": "United States", "bmi": 37.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02951_BMI", "age": 60, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03423", "age": 67, "sex": "Male", "country": "United States", "bmi": 44.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02718", "age": 46, "sex": "Female", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00091_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.7, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01321_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.0, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00465_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01978_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03043_AGE", "age": 5, "sex": "Male", "country": "United States", "bmi": 43.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06560411", "url": "https://clinicaltrials.gov/ct2/show/NCT06560411", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Subject has the ability to provide written informed consent.2. Subject is = 18 years old.3. Subject has documented respiratory failure (e.g. sleep hypoventilation withhistorical transcutaneous carbon dioxide (PtCO2) increase = 10mmHg) and/or daytimehypercapnia (>45 mmHg).4. Subject is currently using non-invasive positive pressure ventilation (NIV) for 1month.5. Subject has a previously documented apnea-hypopnea index (AHI) = 5/hr.6. Subject's expiratory positive airway pressure (EPAP) settings were recently (= 12months) reviewed.Exclusion Criteria:1. Subject is not compliant on NIV (e.g., < 4 hr./night).2. Subject is pregnant.3. Subject is on oxygen therapy = 5 L/min.4. Subject has an invasive interface (e.g. tracheostomy).5. Subject has had an acute exacerbation within the last 3 months that resulted in ahospitalization.6. Subject is acutely ill, medically complicated, or who are medically unstable.7. Subject in whom NIV therapy is otherwise medically contraindicated.8. Subject has had surgery of the upper airway, nose, sinus, or middle ear within theprevious 90 days.9. Subjects with untreated, non-obstructive sleep apnea (OSA) sleep disorders,including but not limited to: insomnia, periodic limb movement syndrome, or restlessleg syndrome. 10. Subjects who have the following pre-existing conditions: severe bullous lungdisease, recurrent pneumothorax or pneumomediastinum, cerebrospinal fluid leak, orrecent cranial surgery or trauma. 11. Subject does not comprehend English. 12. Subject is unable or unwilling to provide written informed consent. 13. Subject is physically and/or mentally unable to comply with the protocol. 14. Subject is not suitable to participate in the trial for any other reason in theopinion of the investigator.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02703_AGE", "age": 12, "sex": "Male", "country": "United States", "bmi": 35.1, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 12", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00479", "age": 12, "sex": "Female", "country": "United States", "bmi": 44.6, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 12", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01940", "age": 8, "sex": "Male", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 12", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01756", "age": 9, "sex": "Female", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 12", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01017_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 12", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02029", "age": 9, "sex": "Male", "country": "United States", "bmi": 18.6, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 12", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00591", "age": 8, "sex": "Female", "country": "United States", "bmi": 36.6, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 6 and 12", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02237_AGE", "age": 19, "sex": "Female", "country": "United States", "bmi": 32.7, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-12"], "rationale": "Failed criteria: Age not in range 6-12", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01866", "age": 26, "sex": "Female", "country": "United States", "bmi": 36.8, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-12"], "rationale": "Failed criteria: Age not in range 6-12", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01727_BMI", "age": 17, "sex": "Female", "country": "United States", "bmi": 94.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-12"], "rationale": "Failed criteria: Age not in range 6-12", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01861_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-12"], "rationale": "Failed criteria: Age not in range 6-12", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03309", "age": 25, "sex": "Male", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-12"], "rationale": "Failed criteria: Age not in range 6-12", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02833_AGE", "age": 18, "sex": "Male", "country": "United States", "bmi": 31.2, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-12"], "rationale": "Failed criteria: Age not in range 6-12", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02618", "age": 25, "sex": "Male", "country": "United States", "bmi": 32.7, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06546696", "url": "https://clinicaltrials.gov/ct2/show/NCT06546696", "status": "Recruiting", "countries": ["United States"], "age_min": 6, "age_max": 12, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Child with an age = 6 years and < 12 years-Child body mass index =95th percentile for age and sex on standardized CDC growthcurves-Index parent/legal guardian with an age =18 years-Parent and child speak English or Spanish-Family resides within or frequently visit selected zip codes within Middle TNsurrounding the partnering community centers;-Have parental commitment to participate in a 6-month study;-Have the ability to view online trainings-Complete baseline data collection, including parent and child height and weight andat least 90% of baseline survey items.Exclusion Criteria:-Participant child has been diagnosed with Down Syndrome, Autism, or any otherdevelopmental disorders that impact metabolism or behaviors that would precludeparticipation in group physical activity settings;-Either the participant caregiver or child is unable to participate in light tomoderate physical activity;-Participant caregiver has a serious mental or neurologic illness that impairsability to consent/participate.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 6-12"], "rationale": "Failed criteria: Age not in range 6-12", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03158", "age": 40, "sex": "Female", "country": "United States", "bmi": 31.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00493", "age": 68, "sex": "Female", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00777", "age": 18, "sex": "Male", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02726_AGE", "age": 21, "sex": "Female", "country": "United States", "bmi": 41.7, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02602_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 28.2, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03166", "age": 70, "sex": "Male", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00683_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-120"], "rationale": "Failed criteria: Age not in range 8-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03478_AGE", "age": 6, "sex": "Female", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-120"], "rationale": "Failed criteria: Age not in range 8-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01506_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-120"], "rationale": "Failed criteria: Age not in range 8-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03294_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 36.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-120"], "rationale": "Failed criteria: Age not in range 8-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02191_AGE", "age": 7, "sex": "Male", "country": "United States", "bmi": 36.1, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06520657", "url": "https://clinicaltrials.gov/ct2/show/NCT06520657", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Family must have one major social risk factor on the Protocol for Responding to &Assessing Patients' Assets, Risks & Experiences (PRAPARE) of the 14 modifiable riskfactors-Child aged 8 through 12 years of age-Child with BMI% at 85th percentile or higher and less than the 120% of the 95thpercentile (overweight or class 1 obesity)-Child must live with parent/guardian at least 5 out of the 7 days on average (70% ofthe time)-Child and parent able to speak EnglishExclusion Criteria:-Child on medications known to cause ongoing weight gain (e.g., atypicalanti-psychotics, chronic prednisone, insulin)-Child on other medications know to affect weight if dose and BMI z-score has notbeen stable for 3 months.-Diabetes or other disease that has a significant effect on diet, physical activity,or ability to take part in trial activities besides obesity (does not includedtreated or mild depression or anxiety, limited food allergies or mild physicalactivity limitations)-For parents: new MI, stroke or cancer diagnosis (excluding localized skin cancers)in past 6 months, history of bariatric surgery within the past 3 years, pregnancy inlast 6 months or planned within 1 year-Child or parent has significant developmental or cognitive impairments or othersignificant medical issue that would interfere with ability to participate orcomplete assessment-Parent or child has significant physical limitation-Parent/child planning to move to from Children's Mercy Kansas City (CMKC) servicearea", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-120"], "rationale": "Failed criteria: Age not in range 8-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02845", "age": 47, "sex": "Male", "country": "United States", "bmi": 38.4, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01327", "age": 47, "sex": "Male", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00239", "age": 51, "sex": "Male", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01003", "age": 70, "sex": "Female", "country": "United States", "bmi": 35.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00028", "age": 53, "sex": "Male", "country": "United States", "bmi": 35.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00323_BMI", "age": 53, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00158", "age": 25, "sex": "Male", "country": "United States", "bmi": 34.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02379_BMI", "age": 52, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02517_AGE", "age": 18, "sex": "Female", "country": "United States", "bmi": 41.8, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02002_AGE", "age": 8, "sex": "Female", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00698_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03451_AGE", "age": 6, "sex": "Male", "country": "United States", "bmi": 39.1, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01835_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 36.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03338_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01025_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00469", "age": 15, "sex": "Male", "country": "United States", "bmi": 30.7, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06486922", "url": "https://clinicaltrials.gov/ct2/show/NCT06486922", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Pregnant with at least 14 weeks estimated gestational age-Self-identify as Hispanic/Latinx-Speak fluent English or Spanish-At least 18 years of age-Has a phone or device to participate in video calls-Receiving or eligible to receive WIC benefitsExclusion Criteria:-Diminished mental capacity-Serious medical or psychiatric illness-Serious fetal illness", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01525_AGE", "age": 24, "sex": "Male", "country": "United States", "bmi": 42.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 44", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01975_BMI", "age": 31, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 44", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03420", "age": 22, "sex": "Female", "country": "United States", "bmi": 37.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 44", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01138", "age": 31, "sex": "Female", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 44", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00214", "age": 42, "sex": "Female", "country": "United States", "bmi": 41.5, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 44", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02807_AGE", "age": 39, "sex": "Female", "country": "United States", "bmi": 45.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 44", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02919", "age": 32, "sex": "Female", "country": "United States", "bmi": 36.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 44", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03491", "age": 48, "sex": "Male", "country": "United States", "bmi": 35.2, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01358", "age": 60, "sex": "Male", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02165_AGE", "age": 9, "sex": "Male", "country": "United States", "bmi": 42.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00818_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02337", "age": 68, "sex": "Female", "country": "United States", "bmi": 33.6, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00021_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.3, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03493_BMI", "age": 47, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02485_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 41.1, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06477120", "url": "https://clinicaltrials.gov/ct2/show/NCT06477120", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 44, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female based on sex assigned at birth-Preconception body mass index (BMI) 40.0 - 50 kg/m2-Singleton pregnancy-Age 18-44 years old-< = to 17 weeks gestational age-Fluency in English to provide consent and complete study procedures-Ability to provide informed consent-Cleared by study doctor and the obstetrician/mid-wife provider to participate-Access to a smartphone to complete intervention proceduresExclusion criteria:-Deemed medically high risk-Multiple pregnancy (e.g., twins)-Type 1 or 2 diabetes mellitus-Early gestational diabetes (diagnosed at < = to17 weeks gestational age through anoral glucose tolerance test)-Currently eating = 12 hours daily-Autoimmune disorder (e.g., rheumatoid arthritis)-iron deficiency anemia-Inflammatory bowel disease-Previous spontaneous preterm birth-History of bariatric surgery-Night shift work-Currently incarcerated", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-44"], "rationale": "Failed criteria: Age not in range 18-44", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00664", "age": 43, "sex": "Female", "country": "United States", "bmi": 35.9, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 27.0 and 45.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01239", "age": 34, "sex": "Female", "country": "United States", "bmi": 32.1, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 27.0 and 45.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01444", "age": 46, "sex": "Male", "country": "United States", "bmi": 30.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 27.0 and 45.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01445", "age": 59, "sex": "Male", "country": "United States", "bmi": 30.2, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 27.0 and 45.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02364_AGE", "age": 20, "sex": "Female", "country": "United States", "bmi": 44.6, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 27.0 and 45.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01960_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.9, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 27.0 and 45.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02445_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 38.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 27.0 and 45.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02486_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 27.0 and 45.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01452_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 27.0 and 45.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02303", "age": 66, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 27.0 and 45.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03359", "age": 10, "sex": "Female", "country": "United States", "bmi": 40.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06393725", "url": "https://clinicaltrials.gov/ct2/show/NCT06393725", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 27.0, "bmi_max": 45.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 27-45-has Bluetooth or wifi connectivity at home (for scale)-goes on Facebook at least 5 days per week over the past 2 weeks-has posted/replied at least once a week in the past 2 weeks (per self-report)-has a smart phoneExclusion Criteria:-Pregnant or lactating or plans to during study period-bipolar disorder, substance abuse, psychosis, bulimia, binge eating disorder, orsevere depression-had bariatric surgery or plans to during the study-currently taking meds affecting weight-lost =5% of weight in past 6 months-participating in another weight loss program or plans to during the study-chronic pain or medical condition that interferes with the ability to exercise-type 1 diabetes-unable to walk  mile unaided without stopping-nicotine user", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 27.0 and 45.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02496", "age": 65, "sex": "Male", "country": "United States", "bmi": 43.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01065", "age": 35, "sex": "Male", "country": "United States", "bmi": 30.7, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01059", "age": 56, "sex": "Male", "country": "United States", "bmi": 39.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02079", "age": 53, "sex": "Male", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02998", "age": 58, "sex": "Female", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00919", "age": 33, "sex": "Male", "country": "United States", "bmi": 35.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01059_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 39.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01393_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00503_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00967", "age": 18, "sex": "Male", "country": "United States", "bmi": 33.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03239", "age": 5, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01019_AGE", "age": 11, "sex": "Female", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06340321", "url": "https://clinicaltrials.gov/ct2/show/NCT06340321", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Individuals who participated in the InSight study at Pennington Biomedical in2008-2009.Exclusion Criteria:-Women who are currently pregnant or breastfeeding, have been pregnant in the last 12months, and/or were breastfeeding in the last 6 months.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02519_BMI", "age": 42, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02925", "age": 50, "sex": "Male", "country": "United States", "bmi": 32.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00444", "age": 28, "sex": "Male", "country": "United States", "bmi": 38.7, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02839", "age": 33, "sex": "Female", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00892", "age": 19, "sex": "Female", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02066", "age": 62, "sex": "Female", "country": "United States", "bmi": 37.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03205", "age": 52, "sex": "Female", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01709_AGE", "age": 4, "sex": "Male", "country": "United States", "bmi": 37.3, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00299_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.3, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01758", "age": 6, "sex": "Male", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03542_AGE", "age": 9, "sex": "Female", "country": "United States", "bmi": 40.3, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01621_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.1, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01994_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06325722", "url": "https://clinicaltrials.gov/ct2/show/NCT06325722", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:1. Stated willingness to comply with all study procedures and availability for theduration of the study2. Adults aged 18-50 years3. Weight stable (< +/- 5 percent over past 6 months) as determined by volunteer report4. Body mass index (BMI) >= 25 kg/m^25. Agreement to adhere to Lifestyle Considerations throughout the study durationEXCLUSION CRITERIA:1. Subjects with cardiac pacemakers or other implants that may be affected by or affectthe DXA measurements2. Inadequate access to equipment required for the study (e.g., too little refrigeratorstorage space or a microwave oven that is too small) as determined by discretion ofPI and/or study team3. Evidence of diseases or conditions that may influence appetite (e.g., cancer,diabetes, alterations of smell or taste post COVID-19), diseases or conditions thataffect the immune system, or other conditions at the discretion of the PI and/orstudy team4. Taking prescription medications or other drugs that may influence metabolism(including but not limited to diet/weight-loss medication, some psychiatricmedications, or other medications at the discretion of the PI and/or study team)5. People unlikely to adhere to a relatively consistent daily and weekly routine andavoid travel during their participation in the study. For example, people withoccupations such as pilots, flight attendants, or frequently travel for work orpleasure.6. Positive pregnancy test or lactating as determined by volunteer report (women only)7. Inability or unwillingness to use birth control between screening and completion ofthe study (women only)8. Symptoms or signs of perimenopause or menopause by volunteer report (women only)9. Regular vigorous exercise >150 min per week as determined by volunteer report 10. Alcohol consumption > 3 drinks per day as determined by volunteer report 11. Regular use of tobacco (smoking, chewing, or vaping), nicotine replacement therapy,or illicit drugs over past 6 months as determined by volunteer report. Subjects mayalso be excluded based on a urine drug test. 12. Psychological conditions as determined by DSM-5 Self-rated Level 1 Cross-cuttingSymptom Measure such as (but not limited to) eating disorders, depression, bipolardisorders, that would be incompatible with safe and successful participation in thisstudy, as determined by investigators 13. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, foodallergies) or a reported dislike of a significant fraction of the study foods 14. Volunteers unwilling or unable to give informed consent 15. Non-English speakers due to unavailability of required questionnaires in otherlanguages", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02181_AGE", "age": 39, "sex": "Female", "country": "United States", "bmi": 42.3, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00979_AGE", "age": 29, "sex": "Female", "country": "United States", "bmi": 33.2, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03261", "age": 32, "sex": "Female", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01207", "age": 34, "sex": "Male", "country": "United States", "bmi": 34.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00117_BMI", "age": 23, "sex": "Male", "country": "United States", "bmi": 26.5, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02712_AGE", "age": 21, "sex": "Male", "country": "United States", "bmi": 37.3, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02673", "age": 41, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02455_AGE", "age": 23, "sex": "Female", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03153", "age": 27, "sex": "Female", "country": "United States", "bmi": 41.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 45", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03550", "age": 47, "sex": "Male", "country": "United States", "bmi": 38.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00391_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 33.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01404_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00502_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02400_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01752_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 37.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02701_AGE", "age": 12, "sex": "Female", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00450", "age": 18, "sex": "Male", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00022_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02230", "age": 13, "sex": "Female", "country": "United States", "bmi": 35.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06280625", "url": "https://clinicaltrials.gov/ct2/show/NCT06280625", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 45, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Male and female between 21-45 years of age-All races/ethnicities-Body mass Index (BMI) > 25 kg/m2 and <40 kg/m2 (i.e., overweight and obesity,excluding severe obesity)-Fat %: > 30% for female or > 20% for maleExclusion Criteria:-Currently smokes or quit smoking nicotine cigarettes, vapes or E-cigarettes for lessthan 6 months ago-Pregnant, breastfeeding, menopausal-Hemoglobin: <11g/dl for female and <13g/dl for male-Blood donation in the past 8 weeks-Gluten intolerance (Gluten allergy, wheat allergy, celiac disease), Soy intoleranceor allergy-Presence of malabsorption syndrome-History of bariatric surgery-Presence of inflammatory intestinal disease, liver, or kidney disease-Diabetes (fasting glucose level >126mg/dl or plasma glucose level 2h after glucosechallenge >200 mg/dl) or taking medicines to treat diabetes-Polycystic ovary syndrome (pcos)-Untreated hypertension-Taking any medication that might affect glucose metabolism or the results of ourstudy-History of cancer <5 years ago-Abnormalities in the metabolic panel test (e.g., liver enzymes >2 times the upperlimit).-Seizures", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-45"], "rationale": "Failed criteria: Age not in range 21-45", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01553", "age": 39, "sex": "Male", "country": "United States", "bmi": 32.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02580", "age": 43, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01630", "age": 70, "sex": "Male", "country": "United States", "bmi": 44.2, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03061", "age": 27, "sex": "Male", "country": "United States", "bmi": 32.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02637_BMI", "age": 29, "sex": "Female", "country": "United States", "bmi": 16.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01535", "age": 46, "sex": "Male", "country": "United States", "bmi": 35.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03445_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01202_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02779_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 35.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01945", "age": 15, "sex": "Female", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01687_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02855_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06273072", "url": "https://clinicaltrials.gov/ct2/show/NCT06273072", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Physician-diagnosed asthma on maintenance therapy-Not well-controlled asthma (ACT score <20, or at least one asthma exacerbationrequiring corticosteroids in the prior 12 months)-Overweight or obesity: Body mass index =25kg/m2-Adult: Age =18Exclusion Criteria:-Currently pregnant, expect to become pregnant in the next 6 months or are currentlybreastfeeding-Major cardiovascular disease: heart failure, heart attack or stroke within the last6 months-Other chronic lung disease, inclusive of chronic obstructive pulmonary disease,bronchiectasis, interstitial lung disease, pulmonary fibrosis-Active smoking or former smoker with =20 pack-year smoking history-Chronic kidney disease: estimated glomerular filtration rate =60 mL/min/1.73 m2-Heavy alcohol use: in a typical week, 8 or more drinks for a woman or 15 or moredrinks for a man-Liver disease: elevation in aspartate aminotransferase (AST) or alanineaminotransferase (ALT) > 2x the upper limit of normal or prior diagnosis of liverdisease-Anemia: hemoglobin < 13 g/dl in males and hemoglobin < 11 g/dl in females-Taking Glucagon Like Peptide 1(GLP-1) medications for weight loss-Diabetes (Hemoglobin A1C = 6.5% or taking metformin or other medications used totreat diabetes)-Participation in any other clinical trial (observational studies are permitted)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02786", "age": 32, "sex": "Male", "country": "United States", "bmi": 44.3, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02183", "age": 40, "sex": "Male", "country": "United States", "bmi": 35.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01158_AGE", "age": 39, "sex": "Male", "country": "United States", "bmi": 42.6, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00417_BMI", "age": 60, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01219", "age": 21, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02836_BMI", "age": 34, "sex": "Male", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01064_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 29.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03534_AGE", "age": 12, "sex": "Male", "country": "United States", "bmi": 34.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01726_AGE", "age": 9, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01405_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 35.5, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02496_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01080_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00966_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06223555", "url": "https://clinicaltrials.gov/ct2/show/NCT06223555", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:In order to be eligible to participate in this study, an individual must meet all of thefollowing criteria:-Provision of signed and dated informed consent form.-Agreement to adhere to Lifestyle Considerations throughout study duration.-Males and females; Age >= 18years-Healthy, as determined by medical history, physical examination, and laboratorytests.EXCLUSION CRITERIA:An individual who meets any of the following criteria will be excluded from participationin thisstudy:-Current use of medications, dietary supplements, or alternative therapies known toalter energy metabolism.-Fasting plasma glucose >= 126 mg/dL-Type I or Type II Diabetes Mellitus by self-report.-Hematologic disorders including significant anemia (male hemoglobin < 13.0 g/dL orfemale hemoglobin < 11.0 g/dL)-Current pregnancy, pregnancy within the past 6 months or currently lactating-History or self-report of gastrointestinal disease, including inflammatory boweldiseases (e.g. Chron s disease and ulcerative colitis), malabsorption syndromes(e.g. celiac disease), gastric ulcer (active) which may alter metabolism orabsorption of study food by self-report-Evidence of alcohol abuse as defined by an 8-point score on the Alcohol consumptionscreening AUDIT questionnaire in adults.-Participants who report taking large doses of acetaminophen (> 3 grams daily) whocannot stop acetaminophen 24 hours prior to and following the meal tests will beexcluded from the study.-Inability to consume provided food based on a food allergy or intolerance.-Conditions not specifically mentioned above may serve as criteria for exclusion atthe discretion of the investigators.-Any disorder, unwillingness, or inability not covered by any other exclusioncriteria which, in the investigator s and/or team s opinion, jeopardizes the safetyof the participant or others or would interfere with adherence to the protocol (suchas claustrophobia).Conditions not specifically mentioned above may serve as criteria for exclusion at thediscretion of the investigators.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00485_AGE", "age": 21, "sex": "Female", "country": "United States", "bmi": 34.0, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01771", "age": 62, "sex": "Male", "country": "United States", "bmi": 30.9, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00395", "age": 47, "sex": "Male", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02465", "age": 32, "sex": "Female", "country": "United States", "bmi": 29.8, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03144", "age": 35, "sex": "Male", "country": "United States", "bmi": 31.2, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02681_BMI", "age": 51, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02769", "age": 67, "sex": "Female", "country": "United States", "bmi": 31.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01040", "age": 20, "sex": "Male", "country": "United States", "bmi": 33.5, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03165", "age": 63, "sex": "Female", "country": "United States", "bmi": 41.3, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01830_AGE", "age": 54, "sex": "Male", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03039_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02594_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 39.1, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01906_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00086_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01692_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.7, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02740_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02632_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.4, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00240_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 36.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06305260", "url": "https://clinicaltrials.gov/ct2/show/NCT06305260", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18 years or older-English Speaking-BMI (Body Mass Index) > 40-Ability to provide informed consent and verbally disclose their medical history Exclusion Criteria:-History of spine surgery, scoliosis, or other spinal abnormality which could complicate epidural placement-Patients with platelet counts <70,000 or patients who are on anticoagulation, or patients who are on anticoagulation, both would exclude any patient from receiving an epidural.-Minors-Adults unable to make their own decisions or with cognitive issues or developmental delays-Prisoners", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00391", "age": 53, "sex": "Female", "country": "United States", "bmi": 33.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02069_BMI", "age": 56, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03207", "age": 34, "sex": "Female", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01922", "age": 23, "sex": "Female", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00986_BMI", "age": 36, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01741_AGE", "age": 20, "sex": "Male", "country": "United States", "bmi": 29.0, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01531", "age": 40, "sex": "Male", "country": "United States", "bmi": 31.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00633", "age": 51, "sex": "Female", "country": "United States", "bmi": 36.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00631", "age": 35, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02274_BMI", "age": 51, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02286_AGE", "age": 9, "sex": "Male", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01332_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 30.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03023_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02587_AGE", "age": 9, "sex": "Male", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01393_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00419_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03294_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 36.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01942_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02193", "age": 12, "sex": "Male", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00614_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06143956", "url": "https://clinicaltrials.gov/ct2/show/NCT06143956", "status": "Recruiting", "countries": ["United States", "Argentina", "United States", "India"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Have a body mass index (BMI)-=30 kilogram/square meter (kg/m), or-=27 kg/m and <30 kg/m), or with at least 1 weight-releated comorbidity-Have had a stable body weight for the 3 months prior to randomization (<5%) bodyweight gain and/or loss.Exclusion Criteria:-Have a prior or planned surgical treatment for obesity, except prior liposuction orabdominoplasty, if performed >1 year prior to screening.-Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history ofketoacidosis or hyperosmolar coma.-Have poorly controlled hypertension.-Have signs and symptoms of any liver disease other than nonalcoholic fatty liverdisease.-Have any of the following cardiovascular conditions within 3 months prior toscreening:-acute myocardial infarction-cerebrovascular accident (stroke)-unstable angina, or-hospitalization due to congestive heart failure.-Have a history of symptomatic gallbladder disease within the past 2 years.-Have a lifetime history of suicide attempts.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00979", "age": 42, "sex": "Female", "country": "United States", "bmi": 33.2, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01361_BMI", "age": 36, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02881", "age": 32, "sex": "Female", "country": "United States", "bmi": 36.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01451", "age": 63, "sex": "Male", "country": "United States", "bmi": 32.2, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00566", "age": 37, "sex": "Male", "country": "United States", "bmi": 40.6, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02246_BMI", "age": 28, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01376_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.7, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03433_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01536_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 37.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01221_AGE", "age": 4, "sex": "Female", "country": "United States", "bmi": 44.2, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00093_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 37.6, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00559_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 39.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00538_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.6, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03477_BMI", "age": 8, "sex": "Male", "country": "United States", "bmi": 84.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01283_AGE", "age": 3, "sex": "Male", "country": "United States", "bmi": 42.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01869_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06116435", "url": "https://clinicaltrials.gov/ct2/show/NCT06116435", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-For all types of research participants:-Men and Women-Age 18-65 years-Have access to a computer and/or smart phone, and Wi-Fi-Speak English (since all study materials are in English and the intervention will be delivered in a group-class setting with a coach who speaks English, we are only able to accommodate English-speakers at this time)-For the patient participants only:-Body Mass Index 25-45 kg/m2-Insufficiently active (defined as <150 min/week of voluntary exercise at moderate intensity over the past 3 months)-Willing not to enroll in any other formal weight loss, or physical activity program over the next 5 months.-Have a primary care physician (or has access to a healthcare professional and/or are willing to establish care with a primary care physician prior to study enrollment) to address medical issues which may arise during screening or study procedures/interventions.-Capable and willing to give informed consent, understand exclusion criteria, attend the Move program sessions, and complete outcome measures.-For the provider participants only:->1 year experience with delivering lifestyle interventions involving changes in diet and/or exercise behaviors. Exclusion Criteria:-For patient participants:-Considered high risk, based on the American College of Sports Medicine Guidelines for Exercise Testing and Prescription (i.e. have cardiovascular disease symptoms or known cardiovascular disease, diabetes, or end-stage renal disease).-Females who are currently pregnant or lactating, were pregnant within the past 3 months, or planning to become pregnant in the next 5 months will also be excluded-Self-reported cardiovascular disease:-Cardiac, peripheral vascular, or cerebrovascular disease-Self-reported symptoms suggestive of cardiovascular disease: pain, discomfort in the chest, neck, jaw, arms, or other areas that may result from cardiac ischemia; shortness of breath at rest or with mild exertion; dizziness or syncope; orthopnea or paroxysmal nocturnal dyspnea; ankle edema; palpitations or tachycardia; intermittent claudication-Self-reported end-stage renal disease-Self-reported diabetes (history of type 1 or type 2 diabetes)-Uncontrolled hypertension, defined as diastolic blood pressure >100 mmHG, systolic blood pressure >160 mmHG, or resting heart rate >100 bpm as measured in duplicate at the screening visit after 5 minutes of rest in a seated position.-Self-reported pulmonary disease requiring chronic oxygen supplementation; severe asthma or chronic obstructive pulmonary disease requiring hospitalization in past year.-Plans to relocate in the next 16 months-Currently participating in or planning to participate in any formal weight loss, dietary modification, or physical activity/exercise programs or clinical trials.-Current severe depression or history of severe depression within the previous year, based on Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria for Major Depressive Episode. Score > 18 on Beck Depression Inventory (BDI) will require further assessment by the Study Medical Doctor (MD) to determine if it is appropriate for the subject to participate in the study.-History of other significant psychiatric illnesses (e.g., psychosis, schizophrenia, mania, bipolar disorder) which in the opinion of the Study MD would interfere with ability to adhere to the exercise intervention.-History of clinically diagnosed eating disorders including anorexia nervosa, bulimia, binge eating disorder. Score >20 on the Eating Attitudes Test (EATS-26) or pattern of response on the Questionnaire on Eating and Weight Patterns-5 (QEWP-5) suggestive of possible binge eating disorder or bulimia will require further assessment by the Study MD to determine if it is appropriate for the subject to participate in the study.-Current alcohol or substance abuse-Nicotine use (current or past 6 months)-Regular use of prescription or over-the-counter medications known to significantly impact appetite, weight, sleep, or energy metabolism (e.g., appetite suppressants, lithium, stimulants, anti-psychotics, tricyclic antidepressants)-Regular use of obesity pharmacotherapeutic agents within the last 6 months.-Previous obesity treatment with surgery or weight loss device, except: (1) liposuction and/or abdominoplasty if performed > 1 year before screening, (2) lap banding if the band has been removed > 1 year before screening, (3) intragastric balloon if the balloon has been removed > 1 year before screening (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed > 1 year before screening or 5) AspireAssist or other endoscopically placed weight loss device if the device has been removed > 1 year before screening.-Currently has access to and uses a fitness membership (defined as having used membership within the past month)-For provider participants:-None", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02066", "age": 62, "sex": "Female", "country": "United States", "bmi": 37.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00926", "age": 58, "sex": "Female", "country": "United States", "bmi": 40.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00887", "age": 56, "sex": "Male", "country": "United States", "bmi": 37.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00930", "age": 67, "sex": "Male", "country": "United States", "bmi": 38.3, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00189_BMI", "age": 56, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02012", "age": 53, "sex": "Female", "country": "United States", "bmi": 37.4, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 50 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03286_BMI", "age": 14, "sex": "Female", "country": "United States", "bmi": 84.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01773_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02137", "age": 18, "sex": "Female", "country": "United States", "bmi": 33.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00476", "age": 7, "sex": "Female", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02211_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00851_AGE", "age": 49, "sex": "Female", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03014", "age": 43, "sex": "Female", "country": "United States", "bmi": 40.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00337", "age": 10, "sex": "Female", "country": "United States", "bmi": 31.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00166", "age": 19, "sex": "Female", "country": "United States", "bmi": 19.0, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00521", "age": 29, "sex": "Male", "country": "United States", "bmi": 41.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06019832", "url": "https://clinicaltrials.gov/ct2/show/NCT06019832", "status": "Recruiting", "countries": ["United States"], "age_min": 50, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria:-Female adult patients with severe osteoarthritis scheduled to have primary totalknee arthroplasty-35 kg/m2 and above-Only patients from the PI's clinic will be included.-Women who are still menstruating and are currently on contraceptives and women whoare in menopause.Exclusion Criteria:-Patients who have some active local or widespread infection (including secondary orinflammatory osteoarthritis)-medical conditions that put them at risk of complications or death during and afterthe study would not be eligible for surgery-Patients with previous knee surgery on arthroplasty site will be excluded-Pregnant patients and women who are capable of getting pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 50-99"], "rationale": "Failed criteria: Age not in range 50-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00884", "age": 19, "sex": "Male", "country": "United States", "bmi": 38.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02081_AGE", "age": 21, "sex": "Male", "country": "United States", "bmi": 33.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03484", "age": 47, "sex": "Male", "country": "United States", "bmi": 39.6, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02566", "age": 22, "sex": "Female", "country": "United States", "bmi": 36.6, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00657_BMI", "age": 34, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02847", "age": 21, "sex": "Female", "country": "United States", "bmi": 37.6, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01625", "age": 42, "sex": "Female", "country": "United States", "bmi": 36.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02534", "age": 46, "sex": "Female", "country": "United States", "bmi": 43.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 50"], "failed_criteria": ["BMI not in range 25.0-40.0"], "rationale": "Failed criteria: BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00392", "age": 34, "sex": "Male", "country": "United States", "bmi": 43.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 50"], "failed_criteria": ["BMI not in range 25.0-40.0"], "rationale": "Failed criteria: BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02727_AGE", "age": 21, "sex": "Male", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 50"], "failed_criteria": ["BMI not in range 25.0-40.0"], "rationale": "Failed criteria: BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00717_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03315_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.6, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01451_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 32.2, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02876_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.8, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00612_BMI", "age": 50, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 50"], "failed_criteria": ["BMI not in range 25.0-40.0"], "rationale": "Failed criteria: BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01431_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02027", "age": 8, "sex": "Male", "country": "United States", "bmi": 14.2, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT06030362", "url": "https://clinicaltrials.gov/ct2/show/NCT06030362", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Ages 18-50-BMI 25-40-Male and Female-Not Pregnant or NursingExclusion Criteria:-Co-morbidities including but not limited to:-Type 1 (insulin dependent) diabetes-vascular disease-drastic weight loss (more than 10lbs over the preceding 2months)-frequent strenuous exercise (i.e. marathon runners/heavy weight lifting)-abdominal surgeries including weight loss surgery or partial/complete resection ofstomach or bowel-untreated thyroid disease-neurological disease-Major medical condition the PI/MD feels would put the subject at risk or interferewith data collection.-Chronic pain-Diagnosed DSM IV active psychiatric illness including eating disorders. Must not beactive or present for at least 2 years. Participants with a positive endorsement onthe MINI+ will be excluded.-Using medications known to affect hunger/satiety/appetite-Pregnant, lactating, postpartum less than 6months.-Women of childbearing potential who are not practicing birth control or are planningto get pregnant during the study.-Use of oral/IV antibiotics within the last 3 months-Use of probiotics in the last 3 months.-Heavy use of alcohol and drugs will be determined by a positive endorsement on theMINI+. If the MINI+ is positive for alcohol or drug dependence or abuse, theparticipant will be excluded. In regards to tobacco use, participants will beexcluded if they smoke more than 1/2 pack per day.-Cannabis use will not be exclusionary. If the MINI+ is positive for drug dependenceor abuse, the participant will be excluded.-Significant change in usual diet and/or weight loss of more than 10lbs in the last 2months.-Anyone taking medicines on the medication exclusion list.-Non-English Speakers (due to the use of validated questionnaires and limitedavailability of translated copies, participants must be fluent in English so thatthey will be able to read and follow directions easily.-Maintenance pharmacotherapies will not be exclusionary so long as they have been ona stable dose for 6months.-Body weight at enrollment greater than 400lbs.-Exclude from Optional MRI if: participant is unable to safely participate in the MRI(claustrophobia, presence of devices affected by MRI such as pacemakers,neurostimulators, metallic foreign bodies, etc.).", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-50", "BMI not in range 25.0-40.0"], "rationale": "Failed criteria: Age not in range 18-50, BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00116", "age": 19, "sex": "Female", "country": "United States", "bmi": 29.3, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02639", "age": 18, "sex": "Male", "country": "United States", "bmi": 20.8, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02098", "age": 22, "sex": "Male", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02983", "age": 40, "sex": "Male", "country": "United States", "bmi": 41.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02605", "age": 39, "sex": "Male", "country": "United States", "bmi": 20.1, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01393_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02106", "age": 14, "sex": "Male", "country": "United States", "bmi": 30.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01025_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01484_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02551", "age": 6, "sex": "Male", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03433_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05975580", "url": "https://clinicaltrials.gov/ct2/show/NCT05975580", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:1. Male and female subjects aged 18-70 years2. Had sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) at least 18 monthsago3. Weight regain of =5% relative to post-surgery nadir weight4. Body mass index (BMI) =30 kg/m2 or =27 kg/m2 with weight-related comorbidities5. Women of childbearing potential must be using appropriate contraception to avoidpregnancy throughout the study, and must have a negative pregnancy test at studyentry6. Must be able to provide written informed consentExclusion Criteria:1. Type 1 diabetes2. Insulin-dependent type 2 diabetes3. Fasting plasma glucose (FPG) =240 mg/dL4. Uncontrolled hypertension defined as systolic blood pressure (SBP) =150 mm Hg and/ordiastolic blood pressure (DBP) =100 mm Hg on the average of three seatedmeasurements after being at rest for at least 5 minutes5. History of significant (as determined by the investigator) and unstablecardiovascular disease including coronary artery disease, arrhythmias, severecongestive heart failure, or stroke6. Use of monoamine oxidase inhibitors, current or within 2 weeks7. Hyperthyroidism or other significant thyroid disease8. Angle-closure glaucoma9. Agitated states 10. History of drug abuse within the past year 11. Known hypersensitivity or idiosyncrasy to sympathomimetic amines 12. Severe hepatic disease (non-alcoholic fatty liver disease or non-alcoholicsteatohepatitis without portal hypertension or cirrhosis is acceptable) 13. End-stage renal disease 14. History of nephrolithiasis 15. Serum triglycerides =500 mg/dL 16. Cancer, not in remission, within the past 2 years except for adequately treatedbasal cell, squamous cell skin cancer, or in-situ cervical cancer 17. History of psychosis or bipolar disorder 18. Suicidal ideation or unstable/untreated major depressive disorder within the pastyear 19. Use of antidepressant medication that has not been at stable dose for at least 3months 20. Hospital Anxiety and Depression Scale (HADS) score of =11 for depression or anxietyitems 21. Binge Eating Scale (BES) score of =27 22. Alcohol use disorder within the past year 23. Epilepsy 24. Currently taking phentermine or topiramate or the combination, or productscontaining these drugs 25. Currently taking stimulants (e.g., Attention Deficit Hyperactivity Disordermedications) 26. Current use of prescription or over-the-counter weight loss drugs or supplements 27. Taking prescription or over-the-counter drugs or products, which in the opinion ofthe PI, could be associated with significant effects on body weight 28. Planning additional bariatric surgery procedures in the next 13 months 29. History of revisional bariatric surgery (revisional surgery after adjustable gastricbanding is acceptable) 30. Currently participating in another weight loss program or have plans to participatein the next 13 months 31. Smoking cessation within the previous 3 months or plans to quit smoking in the next13 months 32. Pregnant or breastfeeding or planning pregnancy in the coming 13 months 33. History of, or any existing condition that, in the opinion of the PrincipalInvestigator, would interfere with the study outcomes or place the subject atunacceptable risk by participating in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00612_BMI", "age": 50, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00404", "age": 34, "sex": "Male", "country": "United States", "bmi": 38.4, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03312", "age": 50, "sex": "Female", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03296", "age": 50, "sex": "Male", "country": "United States", "bmi": 40.0, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01841_AGE", "age": 49, "sex": "Male", "country": "United States", "bmi": 41.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02150", "age": 52, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03494", "age": 54, "sex": "Female", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00966", "age": 34, "sex": "Female", "country": "United States", "bmi": 32.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01669_AGE", "age": 49, "sex": "Male", "country": "United States", "bmi": 36.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00322_BMI", "age": 36, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 25 and 55", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00462_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 30.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00891", "age": 68, "sex": "Female", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02129_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 41.1, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00476_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00542_AGE", "age": 4, "sex": "Male", "country": "United States", "bmi": 44.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03561", "age": 16, "sex": "Female", "country": "United States", "bmi": 43.3, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03473_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00493", "age": 68, "sex": "Female", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05933707", "url": "https://clinicaltrials.gov/ct2/show/NCT05933707", "status": "Recruiting", "countries": ["United States"], "age_min": 25, "age_max": 55, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Metabolically healthy lean subjects must have a BMI =18.5 and =24.9 kg/m; Subjectswith obesity must have a BMI =30.0 and =50.0 kg/m-Metabolically healthy lean and people with metabolically healthy obesity must haveintrahepatic triglyceride (IHTG) content =5%; fasting plasma glucose concentration<100 mg/dl, 2-hr oral glucose tolerance plasma glucose concentration <140 mg/dl,hemoglobin A 1C (HbA1c) =5.6% and HOMA-IR <2.5.-People with metabolically unhealthy obesity must have intrahepatic triglyceride(IHTG) content =5.6%; HOMA-IR =2.5, and HbA1c 5.7%-6.4%, or fasting plasma glucoseconcentration =100 mg/dl, or 2-hr oral glucose tolerance test (OGTT) plasma glucoseconcentration =140 mg/dl.Exclusion Criteria:-History of diabetes, liver disease other than NAFLD or other serious diseases,-Consume excessive amounts of alcohol (>21 units/week for men and >14 units/week forwomen),-Take medications that could affect the study outcome measures, engage in regularexercise (>120 min/week),-Are pregnant or lactating", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 25-55"], "rationale": "Failed criteria: Age not in range 25-55", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00048", "age": 23, "sex": "Male", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 40.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03492", "age": 55, "sex": "Female", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 40.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03589", "age": 33, "sex": "Female", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 40.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02321", "age": 45, "sex": "Male", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 40.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00038", "age": 24, "sex": "Female", "country": "United States", "bmi": 41.8, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 40.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02891", "age": 27, "sex": "Male", "country": "United States", "bmi": 42.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 40.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02079", "age": 53, "sex": "Male", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 40.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01352", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-99", "BMI not in range 40.0-100"], "rationale": "Failed criteria: Age not in range 18-99, BMI not in range 40.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01658", "age": 50, "sex": "Male", "country": "United States", "bmi": 34.0, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 99"], "failed_criteria": ["BMI not in range 40.0-100"], "rationale": "Failed criteria: BMI not in range 40.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01452", "age": 30, "sex": "Male", "country": "United States", "bmi": 37.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 99"], "failed_criteria": ["BMI not in range 40.0-100"], "rationale": "Failed criteria: BMI not in range 40.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02262_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 40.0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01100", "age": 68, "sex": "Male", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 99"], "failed_criteria": ["BMI not in range 40.0-100"], "rationale": "Failed criteria: BMI not in range 40.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02106_BMI", "age": 14, "sex": "Male", "country": "United States", "bmi": 74.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 40.0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02745_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 35.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-99", "BMI not in range 40.0-100"], "rationale": "Failed criteria: Age not in range 18-99, BMI not in range 40.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03477_BMI", "age": 8, "sex": "Male", "country": "United States", "bmi": 84.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05986617", "url": "https://clinicaltrials.gov/ct2/show/NCT05986617", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": 40.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Adults >/= 18 years-BMI > 40kg/m2-Presenting to arthroplasty-obesity clinic with desire for total joint arthroplasty procedure-Owns a smartphone capable of handling iOS or Google Play apps. Exclusion Criteria:-Has a pacemaker or other electronic pacemaker placement-Inability to complete study protocols-Inability to stand unsupported for 60-90 seconds-Does not own a smart phone", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 40.0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02935_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "CTIS2022-503116-16-00", "url": "https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-503116-16-00", "status": "Recruiting", "countries": ["United Kingdom", "Japan", "Canada", "United States", "Netherlands", "Germany"], "age_min": 0, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: Inclusion 1. Patient has documented evidence of acquired HO defined as:  Diagnosis of craniopharyngioma or other brain lesion affecting the hypothalamic region and has undergone surgery, or chemotherapy, or radiation therapy involving the hypothalamus at least 6 months before Screening, OR  Documented injury to the hypothalamus at least 6 months before Screening for which surgery/radiation is not indicated, Inclusion 2. Aged 4 years and older at time of enrollment, Inclusion 3. Documented weight gain associated with the hypothalamic injury either before therapy or following therapy (surgery and/or following chemotherapy or radiotherapy), and a BMI of =30 kg/m2 for patients =18 years of age or BMI =95th percentile for age and sex for patients 4 to <18 years of age based on the US Centers for Disease Control and Prevention criteria., UPD Inclusion 4. Patients must meet contraception requirements as outlined in Section 6.8.9 unless otherwise indicated., Inclusion 5. Ability to communicate well with the Investigator, understand and comply with the requirements of the trial, and understand and sign the written informed consent and/or assent for patients aged <18 years, a parent/legal guardian that can sign., UPD Inclusion 6. If receiving hormone replacement therapy (ie, thyroid hormones, glucocorticoids, growth hormone or other medications known to affect metabolism or weight/body composition), the dose of such therapy has remained stable for at least 2 months prior to Screening. Note: Changes in dose of =25% may be permissible, with the Sponsors approval). If results of free thyroxine (FT4) warrant changes in therapy >50% or the addition of new medication the patient is screen failed and can be reassessed after 2 months. This doesnot apply to patients experiencing adrenal crisis.", "raw_exclusion": "Exclusion criteria: Exclusion 1. Diagnosis of Prader-Willi syndrome (PWS) or Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, neuroendocrine tumor syndrome (ROHHADNET), Exclusion 18. The patient or a relative of the patient is the Investigator or a sub-investigator, research assistant, pharmacist, study coordinator, or other staff directly involved with the conduct of the trial., Exclusion 2. Weight loss >2% in the previous 3 months for patients aged =18 years or >2% reduction in BMI for patients aged 4 to <18 years --NOTE: Dietary and/or exercise regimens, with or without the use of medications, supplements or herbal treatments associated with weight loss (eg, orlistat, lorcaserin, phentermine, topiramate, naltrexone, bupropion, glucagon-like peptide-1 [GLP-1] receptor agonists, etc) are allowed if: - the regimen and/or dose has been stable for at least 3 months prior to randomization - the patient has not experienced weight loss >2% (for patients =18 years) or >2% BMI (for patients aged 4 to <18 years) during the previous 3 months, and - the patient intends to keep the regimen and/or dose stable throughout the course of the trial., Exclusion 3. Bariatric surgery or procedure (eg, gastric bypass/band/sleeve, duodenal switch, gastric balloon, intestinal barrier, etc) within the last 2 years. All patients with a history of bariatric surgery or procedures must be discussed with and receive approval from the Sponsor prior to enrollment., Exclusion 4. Diagnosis of severe psychiatric disorders (eg, schizophrenia, bipolar disorder, personality disorder), or Major Depressive Disorder (MDD) within the previous 2 years, or Screening Patient Health Questionnaire (PHQ)-9/PHQ-A score =15, or any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (CSSRS), or a Childrens Depression Inventory 2 (CDI-2) T-score =70 during Screening, or lifetime history of suicide attempts, or any suicidal behavior in the last month., Exclusion 5. HbA1c >11.0% at Screening., Exclusion 6. Current, clinically significant pulmonary, cardiac, metabolic, or oncologic disease considered severe enough to interfere with the trial and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor or contract research organization (CRO) monitor to determine eligibility., UPD Exclusion 7. End stage renal disease (GFR <15 mL min/1.73 m2) in any age or glomerular filtration rate (GFR) <30 mL/min/1.73 m2 during Screening in patients <12 years of age (GFR is calculated using the Bedside Schwartz Formula for patients <18 years of age)., Exclusion 8. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during Screening will be biopsied and results known to be benign prior to enrollment. If the pre-treatment biopsy results are of significant concern, the patient is not eligible for trial participation., Exclusion 9. History or close family history (parents or siblings) of skin cancer or melanoma (not including noninvasive, infiltrative basal or squamous cell lesion), or patient history of ocular-cutaneous albinism., Exclusion 19. Hypersensitivity to setmelanotide and/or any excipients contained in the investigational drug., Exclusion 10. Participation in any clinical tr"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01111", "age": 42, "sex": "Male", "country": "United States", "bmi": 39.1, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "CTIS2022-503116-16-00", "url": "https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-503116-16-00", "status": "Recruiting", "countries": ["United Kingdom", "Japan", "Canada", "United States", "Netherlands", "Germany"], "age_min": 0, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: Inclusion 1. Patient has documented evidence of acquired HO defined as:  Diagnosis of craniopharyngioma or other brain lesion affecting the hypothalamic region and has undergone surgery, or chemotherapy, or radiation therapy involving the hypothalamus at least 6 months before Screening, OR  Documented injury to the hypothalamus at least 6 months before Screening for which surgery/radiation is not indicated, Inclusion 2. Aged 4 years and older at time of enrollment, Inclusion 3. Documented weight gain associated with the hypothalamic injury either before therapy or following therapy (surgery and/or following chemotherapy or radiotherapy), and a BMI of =30 kg/m2 for patients =18 years of age or BMI =95th percentile for age and sex for patients 4 to <18 years of age based on the US Centers for Disease Control and Prevention criteria., UPD Inclusion 4. Patients must meet contraception requirements as outlined in Section 6.8.9 unless otherwise indicated., Inclusion 5. Ability to communicate well with the Investigator, understand and comply with the requirements of the trial, and understand and sign the written informed consent and/or assent for patients aged <18 years, a parent/legal guardian that can sign., UPD Inclusion 6. If receiving hormone replacement therapy (ie, thyroid hormones, glucocorticoids, growth hormone or other medications known to affect metabolism or weight/body composition), the dose of such therapy has remained stable for at least 2 months prior to Screening. Note: Changes in dose of =25% may be permissible, with the Sponsors approval). If results of free thyroxine (FT4) warrant changes in therapy >50% or the addition of new medication the patient is screen failed and can be reassessed after 2 months. This doesnot apply to patients experiencing adrenal crisis.", "raw_exclusion": "Exclusion criteria: Exclusion 1. Diagnosis of Prader-Willi syndrome (PWS) or Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, neuroendocrine tumor syndrome (ROHHADNET), Exclusion 18. The patient or a relative of the patient is the Investigator or a sub-investigator, research assistant, pharmacist, study coordinator, or other staff directly involved with the conduct of the trial., Exclusion 2. Weight loss >2% in the previous 3 months for patients aged =18 years or >2% reduction in BMI for patients aged 4 to <18 years --NOTE: Dietary and/or exercise regimens, with or without the use of medications, supplements or herbal treatments associated with weight loss (eg, orlistat, lorcaserin, phentermine, topiramate, naltrexone, bupropion, glucagon-like peptide-1 [GLP-1] receptor agonists, etc) are allowed if: - the regimen and/or dose has been stable for at least 3 months prior to randomization - the patient has not experienced weight loss >2% (for patients =18 years) or >2% BMI (for patients aged 4 to <18 years) during the previous 3 months, and - the patient intends to keep the regimen and/or dose stable throughout the course of the trial., Exclusion 3. Bariatric surgery or procedure (eg, gastric bypass/band/sleeve, duodenal switch, gastric balloon, intestinal barrier, etc) within the last 2 years. All patients with a history of bariatric surgery or procedures must be discussed with and receive approval from the Sponsor prior to enrollment., Exclusion 4. Diagnosis of severe psychiatric disorders (eg, schizophrenia, bipolar disorder, personality disorder), or Major Depressive Disorder (MDD) within the previous 2 years, or Screening Patient Health Questionnaire (PHQ)-9/PHQ-A score =15, or any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (CSSRS), or a Childrens Depression Inventory 2 (CDI-2) T-score =70 during Screening, or lifetime history of suicide attempts, or any suicidal behavior in the last month., Exclusion 5. HbA1c >11.0% at Screening., Exclusion 6. Current, clinically significant pulmonary, cardiac, metabolic, or oncologic disease considered severe enough to interfere with the trial and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor or contract research organization (CRO) monitor to determine eligibility., UPD Exclusion 7. End stage renal disease (GFR <15 mL min/1.73 m2) in any age or glomerular filtration rate (GFR) <30 mL/min/1.73 m2 during Screening in patients <12 years of age (GFR is calculated using the Bedside Schwartz Formula for patients <18 years of age)., Exclusion 8. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during Screening will be biopsied and results known to be benign prior to enrollment. If the pre-treatment biopsy results are of significant concern, the patient is not eligible for trial participation., Exclusion 9. History or close family history (parents or siblings) of skin cancer or melanoma (not including noninvasive, infiltrative basal or squamous cell lesion), or patient history of ocular-cutaneous albinism., Exclusion 19. Hypersensitivity to setmelanotide and/or any excipients contained in the investigational drug., Exclusion 10. Participation in any clinical tr"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03072", "age": 68, "sex": "Female", "country": "United States", "bmi": 36.6, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "CTIS2022-503116-16-00", "url": "https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-503116-16-00", "status": "Recruiting", "countries": ["United Kingdom", "Japan", "Canada", "United States", "Netherlands", "Germany"], "age_min": 0, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: Inclusion 1. Patient has documented evidence of acquired HO defined as:  Diagnosis of craniopharyngioma or other brain lesion affecting the hypothalamic region and has undergone surgery, or chemotherapy, or radiation therapy involving the hypothalamus at least 6 months before Screening, OR  Documented injury to the hypothalamus at least 6 months before Screening for which surgery/radiation is not indicated, Inclusion 2. Aged 4 years and older at time of enrollment, Inclusion 3. Documented weight gain associated with the hypothalamic injury either before therapy or following therapy (surgery and/or following chemotherapy or radiotherapy), and a BMI of =30 kg/m2 for patients =18 years of age or BMI =95th percentile for age and sex for patients 4 to <18 years of age based on the US Centers for Disease Control and Prevention criteria., UPD Inclusion 4. Patients must meet contraception requirements as outlined in Section 6.8.9 unless otherwise indicated., Inclusion 5. Ability to communicate well with the Investigator, understand and comply with the requirements of the trial, and understand and sign the written informed consent and/or assent for patients aged <18 years, a parent/legal guardian that can sign., UPD Inclusion 6. If receiving hormone replacement therapy (ie, thyroid hormones, glucocorticoids, growth hormone or other medications known to affect metabolism or weight/body composition), the dose of such therapy has remained stable for at least 2 months prior to Screening. Note: Changes in dose of =25% may be permissible, with the Sponsors approval). If results of free thyroxine (FT4) warrant changes in therapy >50% or the addition of new medication the patient is screen failed and can be reassessed after 2 months. This doesnot apply to patients experiencing adrenal crisis.", "raw_exclusion": "Exclusion criteria: Exclusion 1. Diagnosis of Prader-Willi syndrome (PWS) or Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, neuroendocrine tumor syndrome (ROHHADNET), Exclusion 18. The patient or a relative of the patient is the Investigator or a sub-investigator, research assistant, pharmacist, study coordinator, or other staff directly involved with the conduct of the trial., Exclusion 2. Weight loss >2% in the previous 3 months for patients aged =18 years or >2% reduction in BMI for patients aged 4 to <18 years --NOTE: Dietary and/or exercise regimens, with or without the use of medications, supplements or herbal treatments associated with weight loss (eg, orlistat, lorcaserin, phentermine, topiramate, naltrexone, bupropion, glucagon-like peptide-1 [GLP-1] receptor agonists, etc) are allowed if: - the regimen and/or dose has been stable for at least 3 months prior to randomization - the patient has not experienced weight loss >2% (for patients =18 years) or >2% BMI (for patients aged 4 to <18 years) during the previous 3 months, and - the patient intends to keep the regimen and/or dose stable throughout the course of the trial., Exclusion 3. Bariatric surgery or procedure (eg, gastric bypass/band/sleeve, duodenal switch, gastric balloon, intestinal barrier, etc) within the last 2 years. All patients with a history of bariatric surgery or procedures must be discussed with and receive approval from the Sponsor prior to enrollment., Exclusion 4. Diagnosis of severe psychiatric disorders (eg, schizophrenia, bipolar disorder, personality disorder), or Major Depressive Disorder (MDD) within the previous 2 years, or Screening Patient Health Questionnaire (PHQ)-9/PHQ-A score =15, or any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (CSSRS), or a Childrens Depression Inventory 2 (CDI-2) T-score =70 during Screening, or lifetime history of suicide attempts, or any suicidal behavior in the last month., Exclusion 5. HbA1c >11.0% at Screening., Exclusion 6. Current, clinically significant pulmonary, cardiac, metabolic, or oncologic disease considered severe enough to interfere with the trial and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor or contract research organization (CRO) monitor to determine eligibility., UPD Exclusion 7. End stage renal disease (GFR <15 mL min/1.73 m2) in any age or glomerular filtration rate (GFR) <30 mL/min/1.73 m2 during Screening in patients <12 years of age (GFR is calculated using the Bedside Schwartz Formula for patients <18 years of age)., Exclusion 8. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during Screening will be biopsied and results known to be benign prior to enrollment. If the pre-treatment biopsy results are of significant concern, the patient is not eligible for trial participation., Exclusion 9. History or close family history (parents or siblings) of skin cancer or melanoma (not including noninvasive, infiltrative basal or squamous cell lesion), or patient history of ocular-cutaneous albinism., Exclusion 19. Hypersensitivity to setmelanotide and/or any excipients contained in the investigational drug., Exclusion 10. Participation in any clinical tr"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02518", "age": 28, "sex": "Male", "country": "United States", "bmi": 42.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "CTIS2022-503116-16-00", "url": "https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-503116-16-00", "status": "Recruiting", "countries": ["United Kingdom", "Japan", "Canada", "United States", "Netherlands", "Germany"], "age_min": 0, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: Inclusion 1. Patient has documented evidence of acquired HO defined as:  Diagnosis of craniopharyngioma or other brain lesion affecting the hypothalamic region and has undergone surgery, or chemotherapy, or radiation therapy involving the hypothalamus at least 6 months before Screening, OR  Documented injury to the hypothalamus at least 6 months before Screening for which surgery/radiation is not indicated, Inclusion 2. Aged 4 years and older at time of enrollment, Inclusion 3. Documented weight gain associated with the hypothalamic injury either before therapy or following therapy (surgery and/or following chemotherapy or radiotherapy), and a BMI of =30 kg/m2 for patients =18 years of age or BMI =95th percentile for age and sex for patients 4 to <18 years of age based on the US Centers for Disease Control and Prevention criteria., UPD Inclusion 4. Patients must meet contraception requirements as outlined in Section 6.8.9 unless otherwise indicated., Inclusion 5. Ability to communicate well with the Investigator, understand and comply with the requirements of the trial, and understand and sign the written informed consent and/or assent for patients aged <18 years, a parent/legal guardian that can sign., UPD Inclusion 6. If receiving hormone replacement therapy (ie, thyroid hormones, glucocorticoids, growth hormone or other medications known to affect metabolism or weight/body composition), the dose of such therapy has remained stable for at least 2 months prior to Screening. Note: Changes in dose of =25% may be permissible, with the Sponsors approval). If results of free thyroxine (FT4) warrant changes in therapy >50% or the addition of new medication the patient is screen failed and can be reassessed after 2 months. This doesnot apply to patients experiencing adrenal crisis.", "raw_exclusion": "Exclusion criteria: Exclusion 1. Diagnosis of Prader-Willi syndrome (PWS) or Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, neuroendocrine tumor syndrome (ROHHADNET), Exclusion 18. The patient or a relative of the patient is the Investigator or a sub-investigator, research assistant, pharmacist, study coordinator, or other staff directly involved with the conduct of the trial., Exclusion 2. Weight loss >2% in the previous 3 months for patients aged =18 years or >2% reduction in BMI for patients aged 4 to <18 years --NOTE: Dietary and/or exercise regimens, with or without the use of medications, supplements or herbal treatments associated with weight loss (eg, orlistat, lorcaserin, phentermine, topiramate, naltrexone, bupropion, glucagon-like peptide-1 [GLP-1] receptor agonists, etc) are allowed if: - the regimen and/or dose has been stable for at least 3 months prior to randomization - the patient has not experienced weight loss >2% (for patients =18 years) or >2% BMI (for patients aged 4 to <18 years) during the previous 3 months, and - the patient intends to keep the regimen and/or dose stable throughout the course of the trial., Exclusion 3. Bariatric surgery or procedure (eg, gastric bypass/band/sleeve, duodenal switch, gastric balloon, intestinal barrier, etc) within the last 2 years. All patients with a history of bariatric surgery or procedures must be discussed with and receive approval from the Sponsor prior to enrollment., Exclusion 4. Diagnosis of severe psychiatric disorders (eg, schizophrenia, bipolar disorder, personality disorder), or Major Depressive Disorder (MDD) within the previous 2 years, or Screening Patient Health Questionnaire (PHQ)-9/PHQ-A score =15, or any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (CSSRS), or a Childrens Depression Inventory 2 (CDI-2) T-score =70 during Screening, or lifetime history of suicide attempts, or any suicidal behavior in the last month., Exclusion 5. HbA1c >11.0% at Screening., Exclusion 6. Current, clinically significant pulmonary, cardiac, metabolic, or oncologic disease considered severe enough to interfere with the trial and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor or contract research organization (CRO) monitor to determine eligibility., UPD Exclusion 7. End stage renal disease (GFR <15 mL min/1.73 m2) in any age or glomerular filtration rate (GFR) <30 mL/min/1.73 m2 during Screening in patients <12 years of age (GFR is calculated using the Bedside Schwartz Formula for patients <18 years of age)., Exclusion 8. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during Screening will be biopsied and results known to be benign prior to enrollment. If the pre-treatment biopsy results are of significant concern, the patient is not eligible for trial participation., Exclusion 9. History or close family history (parents or siblings) of skin cancer or melanoma (not including noninvasive, infiltrative basal or squamous cell lesion), or patient history of ocular-cutaneous albinism., Exclusion 19. Hypersensitivity to setmelanotide and/or any excipients contained in the investigational drug., Exclusion 10. Participation in any clinical tr"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03600", "age": 38, "sex": "Female", "country": "United States", "bmi": 36.8, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "CTIS2022-503116-16-00", "url": "https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-503116-16-00", "status": "Recruiting", "countries": ["United Kingdom", "Japan", "Canada", "United States", "Netherlands", "Germany"], "age_min": 0, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: Inclusion 1. Patient has documented evidence of acquired HO defined as:  Diagnosis of craniopharyngioma or other brain lesion affecting the hypothalamic region and has undergone surgery, or chemotherapy, or radiation therapy involving the hypothalamus at least 6 months before Screening, OR  Documented injury to the hypothalamus at least 6 months before Screening for which surgery/radiation is not indicated, Inclusion 2. Aged 4 years and older at time of enrollment, Inclusion 3. Documented weight gain associated with the hypothalamic injury either before therapy or following therapy (surgery and/or following chemotherapy or radiotherapy), and a BMI of =30 kg/m2 for patients =18 years of age or BMI =95th percentile for age and sex for patients 4 to <18 years of age based on the US Centers for Disease Control and Prevention criteria., UPD Inclusion 4. Patients must meet contraception requirements as outlined in Section 6.8.9 unless otherwise indicated., Inclusion 5. Ability to communicate well with the Investigator, understand and comply with the requirements of the trial, and understand and sign the written informed consent and/or assent for patients aged <18 years, a parent/legal guardian that can sign., UPD Inclusion 6. If receiving hormone replacement therapy (ie, thyroid hormones, glucocorticoids, growth hormone or other medications known to affect metabolism or weight/body composition), the dose of such therapy has remained stable for at least 2 months prior to Screening. Note: Changes in dose of =25% may be permissible, with the Sponsors approval). If results of free thyroxine (FT4) warrant changes in therapy >50% or the addition of new medication the patient is screen failed and can be reassessed after 2 months. This doesnot apply to patients experiencing adrenal crisis.", "raw_exclusion": "Exclusion criteria: Exclusion 1. Diagnosis of Prader-Willi syndrome (PWS) or Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, neuroendocrine tumor syndrome (ROHHADNET), Exclusion 18. The patient or a relative of the patient is the Investigator or a sub-investigator, research assistant, pharmacist, study coordinator, or other staff directly involved with the conduct of the trial., Exclusion 2. Weight loss >2% in the previous 3 months for patients aged =18 years or >2% reduction in BMI for patients aged 4 to <18 years --NOTE: Dietary and/or exercise regimens, with or without the use of medications, supplements or herbal treatments associated with weight loss (eg, orlistat, lorcaserin, phentermine, topiramate, naltrexone, bupropion, glucagon-like peptide-1 [GLP-1] receptor agonists, etc) are allowed if: - the regimen and/or dose has been stable for at least 3 months prior to randomization - the patient has not experienced weight loss >2% (for patients =18 years) or >2% BMI (for patients aged 4 to <18 years) during the previous 3 months, and - the patient intends to keep the regimen and/or dose stable throughout the course of the trial., Exclusion 3. Bariatric surgery or procedure (eg, gastric bypass/band/sleeve, duodenal switch, gastric balloon, intestinal barrier, etc) within the last 2 years. All patients with a history of bariatric surgery or procedures must be discussed with and receive approval from the Sponsor prior to enrollment., Exclusion 4. Diagnosis of severe psychiatric disorders (eg, schizophrenia, bipolar disorder, personality disorder), or Major Depressive Disorder (MDD) within the previous 2 years, or Screening Patient Health Questionnaire (PHQ)-9/PHQ-A score =15, or any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (CSSRS), or a Childrens Depression Inventory 2 (CDI-2) T-score =70 during Screening, or lifetime history of suicide attempts, or any suicidal behavior in the last month., Exclusion 5. HbA1c >11.0% at Screening., Exclusion 6. Current, clinically significant pulmonary, cardiac, metabolic, or oncologic disease considered severe enough to interfere with the trial and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor or contract research organization (CRO) monitor to determine eligibility., UPD Exclusion 7. End stage renal disease (GFR <15 mL min/1.73 m2) in any age or glomerular filtration rate (GFR) <30 mL/min/1.73 m2 during Screening in patients <12 years of age (GFR is calculated using the Bedside Schwartz Formula for patients <18 years of age)., Exclusion 8. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during Screening will be biopsied and results known to be benign prior to enrollment. If the pre-treatment biopsy results are of significant concern, the patient is not eligible for trial participation., Exclusion 9. History or close family history (parents or siblings) of skin cancer or melanoma (not including noninvasive, infiltrative basal or squamous cell lesion), or patient history of ocular-cutaneous albinism., Exclusion 19. Hypersensitivity to setmelanotide and/or any excipients contained in the investigational drug., Exclusion 10. Participation in any clinical tr"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02659_AGE", "age": 34, "sex": "Male", "country": "United States", "bmi": 35.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "CTIS2022-503116-16-00", "url": "https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-503116-16-00", "status": "Recruiting", "countries": ["United Kingdom", "Japan", "Canada", "United States", "Netherlands", "Germany"], "age_min": 0, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: Inclusion 1. Patient has documented evidence of acquired HO defined as:  Diagnosis of craniopharyngioma or other brain lesion affecting the hypothalamic region and has undergone surgery, or chemotherapy, or radiation therapy involving the hypothalamus at least 6 months before Screening, OR  Documented injury to the hypothalamus at least 6 months before Screening for which surgery/radiation is not indicated, Inclusion 2. Aged 4 years and older at time of enrollment, Inclusion 3. Documented weight gain associated with the hypothalamic injury either before therapy or following therapy (surgery and/or following chemotherapy or radiotherapy), and a BMI of =30 kg/m2 for patients =18 years of age or BMI =95th percentile for age and sex for patients 4 to <18 years of age based on the US Centers for Disease Control and Prevention criteria., UPD Inclusion 4. Patients must meet contraception requirements as outlined in Section 6.8.9 unless otherwise indicated., Inclusion 5. Ability to communicate well with the Investigator, understand and comply with the requirements of the trial, and understand and sign the written informed consent and/or assent for patients aged <18 years, a parent/legal guardian that can sign., UPD Inclusion 6. If receiving hormone replacement therapy (ie, thyroid hormones, glucocorticoids, growth hormone or other medications known to affect metabolism or weight/body composition), the dose of such therapy has remained stable for at least 2 months prior to Screening. Note: Changes in dose of =25% may be permissible, with the Sponsors approval). If results of free thyroxine (FT4) warrant changes in therapy >50% or the addition of new medication the patient is screen failed and can be reassessed after 2 months. This doesnot apply to patients experiencing adrenal crisis.", "raw_exclusion": "Exclusion criteria: Exclusion 1. Diagnosis of Prader-Willi syndrome (PWS) or Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, neuroendocrine tumor syndrome (ROHHADNET), Exclusion 18. The patient or a relative of the patient is the Investigator or a sub-investigator, research assistant, pharmacist, study coordinator, or other staff directly involved with the conduct of the trial., Exclusion 2. Weight loss >2% in the previous 3 months for patients aged =18 years or >2% reduction in BMI for patients aged 4 to <18 years --NOTE: Dietary and/or exercise regimens, with or without the use of medications, supplements or herbal treatments associated with weight loss (eg, orlistat, lorcaserin, phentermine, topiramate, naltrexone, bupropion, glucagon-like peptide-1 [GLP-1] receptor agonists, etc) are allowed if: - the regimen and/or dose has been stable for at least 3 months prior to randomization - the patient has not experienced weight loss >2% (for patients =18 years) or >2% BMI (for patients aged 4 to <18 years) during the previous 3 months, and - the patient intends to keep the regimen and/or dose stable throughout the course of the trial., Exclusion 3. Bariatric surgery or procedure (eg, gastric bypass/band/sleeve, duodenal switch, gastric balloon, intestinal barrier, etc) within the last 2 years. All patients with a history of bariatric surgery or procedures must be discussed with and receive approval from the Sponsor prior to enrollment., Exclusion 4. Diagnosis of severe psychiatric disorders (eg, schizophrenia, bipolar disorder, personality disorder), or Major Depressive Disorder (MDD) within the previous 2 years, or Screening Patient Health Questionnaire (PHQ)-9/PHQ-A score =15, or any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (CSSRS), or a Childrens Depression Inventory 2 (CDI-2) T-score =70 during Screening, or lifetime history of suicide attempts, or any suicidal behavior in the last month., Exclusion 5. HbA1c >11.0% at Screening., Exclusion 6. Current, clinically significant pulmonary, cardiac, metabolic, or oncologic disease considered severe enough to interfere with the trial and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor or contract research organization (CRO) monitor to determine eligibility., UPD Exclusion 7. End stage renal disease (GFR <15 mL min/1.73 m2) in any age or glomerular filtration rate (GFR) <30 mL/min/1.73 m2 during Screening in patients <12 years of age (GFR is calculated using the Bedside Schwartz Formula for patients <18 years of age)., Exclusion 8. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during Screening will be biopsied and results known to be benign prior to enrollment. If the pre-treatment biopsy results are of significant concern, the patient is not eligible for trial participation., Exclusion 9. History or close family history (parents or siblings) of skin cancer or melanoma (not including noninvasive, infiltrative basal or squamous cell lesion), or patient history of ocular-cutaneous albinism., Exclusion 19. Hypersensitivity to setmelanotide and/or any excipients contained in the investigational drug., Exclusion 10. Participation in any clinical tr"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03175_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "CTIS2022-503116-16-00", "url": "https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2022-503116-16-00", "status": "Recruiting", "countries": ["United Kingdom", "Japan", "Canada", "United States", "Netherlands", "Germany"], "age_min": 0, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: Inclusion 1. Patient has documented evidence of acquired HO defined as:  Diagnosis of craniopharyngioma or other brain lesion affecting the hypothalamic region and has undergone surgery, or chemotherapy, or radiation therapy involving the hypothalamus at least 6 months before Screening, OR  Documented injury to the hypothalamus at least 6 months before Screening for which surgery/radiation is not indicated, Inclusion 2. Aged 4 years and older at time of enrollment, Inclusion 3. Documented weight gain associated with the hypothalamic injury either before therapy or following therapy (surgery and/or following chemotherapy or radiotherapy), and a BMI of =30 kg/m2 for patients =18 years of age or BMI =95th percentile for age and sex for patients 4 to <18 years of age based on the US Centers for Disease Control and Prevention criteria., UPD Inclusion 4. Patients must meet contraception requirements as outlined in Section 6.8.9 unless otherwise indicated., Inclusion 5. Ability to communicate well with the Investigator, understand and comply with the requirements of the trial, and understand and sign the written informed consent and/or assent for patients aged <18 years, a parent/legal guardian that can sign., UPD Inclusion 6. If receiving hormone replacement therapy (ie, thyroid hormones, glucocorticoids, growth hormone or other medications known to affect metabolism or weight/body composition), the dose of such therapy has remained stable for at least 2 months prior to Screening. Note: Changes in dose of =25% may be permissible, with the Sponsors approval). If results of free thyroxine (FT4) warrant changes in therapy >50% or the addition of new medication the patient is screen failed and can be reassessed after 2 months. This doesnot apply to patients experiencing adrenal crisis.", "raw_exclusion": "Exclusion criteria: Exclusion 1. Diagnosis of Prader-Willi syndrome (PWS) or Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, neuroendocrine tumor syndrome (ROHHADNET), Exclusion 18. The patient or a relative of the patient is the Investigator or a sub-investigator, research assistant, pharmacist, study coordinator, or other staff directly involved with the conduct of the trial., Exclusion 2. Weight loss >2% in the previous 3 months for patients aged =18 years or >2% reduction in BMI for patients aged 4 to <18 years --NOTE: Dietary and/or exercise regimens, with or without the use of medications, supplements or herbal treatments associated with weight loss (eg, orlistat, lorcaserin, phentermine, topiramate, naltrexone, bupropion, glucagon-like peptide-1 [GLP-1] receptor agonists, etc) are allowed if: - the regimen and/or dose has been stable for at least 3 months prior to randomization - the patient has not experienced weight loss >2% (for patients =18 years) or >2% BMI (for patients aged 4 to <18 years) during the previous 3 months, and - the patient intends to keep the regimen and/or dose stable throughout the course of the trial., Exclusion 3. Bariatric surgery or procedure (eg, gastric bypass/band/sleeve, duodenal switch, gastric balloon, intestinal barrier, etc) within the last 2 years. All patients with a history of bariatric surgery or procedures must be discussed with and receive approval from the Sponsor prior to enrollment., Exclusion 4. Diagnosis of severe psychiatric disorders (eg, schizophrenia, bipolar disorder, personality disorder), or Major Depressive Disorder (MDD) within the previous 2 years, or Screening Patient Health Questionnaire (PHQ)-9/PHQ-A score =15, or any suicidal ideation of type 4 or 5 on the Columbia-Suicide Severity Rating Scale (CSSRS), or a Childrens Depression Inventory 2 (CDI-2) T-score =70 during Screening, or lifetime history of suicide attempts, or any suicidal behavior in the last month., Exclusion 5. HbA1c >11.0% at Screening., Exclusion 6. Current, clinically significant pulmonary, cardiac, metabolic, or oncologic disease considered severe enough to interfere with the trial and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor or contract research organization (CRO) monitor to determine eligibility., UPD Exclusion 7. End stage renal disease (GFR <15 mL min/1.73 m2) in any age or glomerular filtration rate (GFR) <30 mL/min/1.73 m2 during Screening in patients <12 years of age (GFR is calculated using the Bedside Schwartz Formula for patients <18 years of age)., Exclusion 8. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion), determined as part of a comprehensive skin evaluation performed by the Investigator during Screening. Any concerning lesions identified during Screening will be biopsied and results known to be benign prior to enrollment. If the pre-treatment biopsy results are of significant concern, the patient is not eligible for trial participation., Exclusion 9. History or close family history (parents or siblings) of skin cancer or melanoma (not including noninvasive, infiltrative basal or squamous cell lesion), or patient history of ocular-cutaneous albinism., Exclusion 19. Hypersensitivity to setmelanotide and/or any excipients contained in the investigational drug., Exclusion 10. Participation in any clinical tr"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00109", "age": 26, "sex": "Female", "country": "United States", "bmi": 38.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00774", "age": 43, "sex": "Male", "country": "United States", "bmi": 35.7, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00949", "age": 41, "sex": "Female", "country": "United States", "bmi": 33.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03395_AGE", "age": 24, "sex": "Male", "country": "United States", "bmi": 40.7, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00910", "age": 48, "sex": "Female", "country": "United States", "bmi": 34.1, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03403", "age": 24, "sex": "Female", "country": "United States", "bmi": 37.0, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01423", "age": 29, "sex": "Female", "country": "United States", "bmi": 32.0, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01793", "age": 46, "sex": "Female", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03499", "age": 45, "sex": "Male", "country": "United States", "bmi": 35.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01773_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-50"], "rationale": "Failed criteria: Age not in range 21-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02176_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-50"], "rationale": "Failed criteria: Age not in range 21-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01419_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.6, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-50"], "rationale": "Failed criteria: Age not in range 21-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02621_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.8, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-50"], "rationale": "Failed criteria: Age not in range 21-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00295_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 30.9, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-50"], "rationale": "Failed criteria: Age not in range 21-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01007_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.7, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05849181", "url": "https://clinicaltrials.gov/ct2/show/NCT05849181", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-African American men and women-Aged 21-50 years-BMI = 27 to 45 kg/m2-Self-report of short or poor sleepers (>5 < 7hrs /night and/or a score > 5 on thePSQI),-Sleeping between 22:00 and 08:00.-Ability to provide informed consent before any trial-related activities-Controlled hypertension or dyslipidemia.Exclusion Criteria:-Previous diagnosis or reveled during the screening PSG (Polysomnography) ofobstructive sleep apnea (AHI=30) or other sleep disorders based on DSM-V (Diagnosticand Statistical Manual of Mental Disorders, fifth edition) criteria.-Shift work-Diagnosis of diabetes based on history or screening tests-History of cognitive or other neurological disorders-History of major psychiatric disorder based on DSM-V criteria-Presence of unstable or serious medical conditions-Use within the past month of melatonin, psychoactive, hypnotic, stimulant or painmedications (except occasionally)-Caffeine consumption of greater than 500 mg per day-Medically managed weight loss program within the past 6 months-History of bariatric weight loss surgery.-Women who are pregnant, plan on becoming pregnant, are breastfeeding,-Men or women who have a child at home that does not sleep through the night.-Active drug/alcohol dependence or abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-50"], "rationale": "Failed criteria: Age not in range 21-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02683", "age": 58, "sex": "Male", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 25.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00784_AGE", "age": 39, "sex": "Female", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 25.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02792", "age": 44, "sex": "Female", "country": "United States", "bmi": 36.6, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 25.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03597_BMI", "age": 22, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 25.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00431", "age": 39, "sex": "Male", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 25.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00523", "age": 70, "sex": "Female", "country": "United States", "bmi": 37.4, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 25.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01280_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 38.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 55.0"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03312_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 55.0"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01665_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 55.0"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01537_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.6, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 55.0"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02120_AGE", "age": 11, "sex": "Female", "country": "United States", "bmi": 33.9, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05796141", "url": "https://clinicaltrials.gov/ct2/show/NCT05796141", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 25.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Married/cohabitating couple - both partners must be eligible-BMI between 25-55kg/m2-English speaking/reading-Have a smartphone and reliable internet access-Have active email address-Willing to videoconferenceExclusion Criteria:-Report being unable to walk 2 blocks without stopping-Are currently participating in weight loss treatment, have a history of bariatricsurgery, or lost =5% in the past 6-months-Are pregnant or plan to become pregnant during the study period-Report chest pain or loss of consciousness on the Physical Activity ReadinessQuestionnaire-Report a medical condition that could jeopardize their safety in a weight controlprogram with diet and exercise guidelines-Report conditions that, in the judgment of the PI, would render them unlikely tofollow the protocol (e.g. dementia)", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 55.0"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01829", "age": 63, "sex": "Male", "country": "United States", "bmi": 44.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00877", "age": 27, "sex": "Male", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03505", "age": 69, "sex": "Male", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03190", "age": 24, "sex": "Female", "country": "United States", "bmi": 41.4, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02058_BMI", "age": 51, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00690_BMI", "age": 46, "sex": "Female", "country": "United States", "bmi": 44.5, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03111", "age": 49, "sex": "Male", "country": "United States", "bmi": 34.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02775", "age": 47, "sex": "Female", "country": "United States", "bmi": 40.7, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02998", "age": 58, "sex": "Female", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 22 and 69", "BMI between 30.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02226_BMI", "age": 11, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 22-69", "BMI not in range 30.0-50.0"], "rationale": "Failed criteria: Age not in range 22-69, BMI not in range 30.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03185_BMI", "age": 30, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 22 and 69"], "failed_criteria": ["BMI not in range 30.0-50.0"], "rationale": "Failed criteria: BMI not in range 30.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02576_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 50.0"], "failed_criteria": ["Age not in range 22-69"], "rationale": "Failed criteria: Age not in range 22-69", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00600_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 37.9, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 50.0"], "failed_criteria": ["Age not in range 22-69"], "rationale": "Failed criteria: Age not in range 22-69", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03499_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 35.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 50.0"], "failed_criteria": ["Age not in range 22-69"], "rationale": "Failed criteria: Age not in range 22-69", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00384_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05739162", "url": "https://clinicaltrials.gov/ct2/show/NCT05739162", "status": "Recruiting", "countries": ["United States"], "age_min": 22, "age_max": 69, "bmi_min": 30.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 30-50 kg/m2 for at least 6 months prior to ESG-Diagnosis of UC with plans to undergo or who have already undergone colectomy aspart of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)-Willing to adhere to the diet and behavior modifications required for ESG-Able to follow the visit schedule-Able to provide informed consent-If female, be either post-menopausal, surgically sterile, or agree to practice birthcontrol during year of study and have negative serum Human Chorionic Gonadotropin(HCG) at screening/baselineExclusion Criteria:-Prior gastric or bariatric surgery or other alteration to upper gastrointestinalanatomy which would preclude safe or technical performance of ESG-Current or recent (last six months) gastric or duodenal ulceration-Esophageal or gastric varices-Significant motility disorder of the esophagus or stomach-Large hiatal hernia measuring >5 cm or = 5 cm and associated with severegastroesophageal reflux-Severe coagulopathy, hepatic insufficiency, or cirrhosis-Gastric mass-Presence of any other medical condition which precludes safe performance of electiveendoscopy such as poor general health and/or history of severe hepatic, cardiac, orpulmonary disease-Serious or uncontrolled psychiatric illness which may compromise patientunderstanding of procedure or compliance with follow-up visits-Unwilling to participate in an established diet and behavior modification program,with routine follow-up-Ongoing corticosteroid use at a dose of >5 mg daily-Daily use of anti-inflammatory agents such as non-steroidal medications, oranticoagulants without medical supervision-Alcohol or drug addiction-Females who are pregnant, nursing, or planning pregnancy within the next year-Concomitant use of or unwillingness to avoid any use of weight loss medications,weight loss supplements, or weight loss herbal preparations-Has a condition or is in a situation which in the investigator's opinion may put thesubject at significant risk or may interfere significantly with the subject'sparticipation in the study", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 50.0"], "failed_criteria": ["Age not in range 22-69"], "rationale": "Failed criteria: Age not in range 22-69", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03095", "age": 32, "sex": "Female", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03407", "age": 39, "sex": "Male", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03113", "age": 44, "sex": "Male", "country": "United States", "bmi": 41.1, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02695", "age": 56, "sex": "Female", "country": "United States", "bmi": 33.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02923_AGE", "age": 18, "sex": "Female", "country": "United States", "bmi": 30.7, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02312", "age": 65, "sex": "Male", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02048", "age": 24, "sex": "Male", "country": "United States", "bmi": 33.1, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00621", "age": 59, "sex": "Female", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02398_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.8, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00907_BMI", "age": 32, "sex": "Male", "country": "United States", "bmi": 26.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 80"], "failed_criteria": ["BMI not in range 30.0-100"], "rationale": "Failed criteria: BMI not in range 30.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02150_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01617_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00824_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05746039", "url": "https://clinicaltrials.gov/ct2/show/NCT05746039", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Diagnosis of one of the following lung diseases: interstitial lung disease,sarcoidosis, chronic obstructive pulmonary disease, or pulmonary hypertension-Age > 18-BMI > 30 kg/m2-Requires supplemental oxygen on exertion-Stable treatment regimen X 90 days-Use of disease-modifying therapyExclusion Criteria:-Diabetes-Pregnant or Breastfeeding-Recent weight loss-Recent or chronic GI complaints-History of gastroparesis-History of scleroderma-Hospitalized at time of evaluation-Use of weight loss medication in last 90 days-Personal or family history of medullary thyroid cancer or multiple endocrineneoplasia (type 2)-Uncontrolled thyroid disease-History of acute/chronic pancreatitis-Prior suicide attempt-Suicidal ideation in last 90 days-Presence of a pacemaker or defibrillator", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01121", "age": 51, "sex": "Female", "country": "United States", "bmi": 32.0, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02282", "age": 51, "sex": "Female", "country": "United States", "bmi": 33.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02783", "age": 22, "sex": "Male", "country": "United States", "bmi": 34.2, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01291", "age": 62, "sex": "Male", "country": "United States", "bmi": 33.8, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01876", "age": 24, "sex": "Male", "country": "United States", "bmi": 38.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 21 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03238", "age": 8, "sex": "Male", "country": "United States", "bmi": 41.5, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02424_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02177_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02442_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.8, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00469_AGE", "age": 3, "sex": "Male", "country": "United States", "bmi": 30.7, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03012", "age": 19, "sex": "Female", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00767_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00544", "age": 8, "sex": "Female", "country": "United States", "bmi": 43.0, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05698693", "url": "https://clinicaltrials.gov/ct2/show/NCT05698693", "status": "Recruiting", "countries": ["United States"], "age_min": 21, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Not meeting Physical Activity Guidelines-age range: 21 to 65 years-body mass index range: 25.0 to 40 kg/m2-average self-reported habitual sleep duration of =6 hours-self-identify as Black or African American.Exclusion Criteria:-Self-reported organ-related disorder (COPD, cardiac arrhythmia, gastro-esophagealdisorder)-pregnant or less than 4 months postpartum-infant living in household less than 1 year old", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 21-65"], "rationale": "Failed criteria: Age not in range 21-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00411_BMI", "age": 24, "sex": "Female", "country": "United States", "bmi": 17.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02527", "age": 50, "sex": "Male", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00298", "age": 44, "sex": "Female", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01544_BMI", "age": 41, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00332", "age": 62, "sex": "Male", "country": "United States", "bmi": 33.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02101", "age": 28, "sex": "Male", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01292_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03257_AGE", "age": 7, "sex": "Male", "country": "United States", "bmi": 37.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02221_AGE", "age": 13, "sex": "Male", "country": "United States", "bmi": 27.7, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02603_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03085", "age": 11, "sex": "Male", "country": "United States", "bmi": 31.7, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01896_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 44.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02370_AGE", "age": 12, "sex": "Male", "country": "United States", "bmi": 42.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01545_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.1, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00600_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 37.9, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00108_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05228860", "url": "https://clinicaltrials.gov/ct2/show/NCT05228860", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-For main study (index/intervention) participants:-Age at enrollment: 18+ years-Self-identified ethnicity: Hispanic, Latino, Chicano, or Spanish-Type 2 diabetes indicated in the electronic health record, e.g. as ICD-10(International Classification of Diseases) diagnosis code or HbA1c value-Have indicated food insecurity according to the screening 2-item Hunger VitalSign questionnaire-Have a Body Mass Index (BMI) => 25-Receiving care at our partnering community health centers (e.g., Clinica de laRaza)-Currently residing in Alameda or Contra Costa County and not expecting torelocate in the next 6-12 months-Have access to phone or computer, email, and some internet for access to remoteintervention and completion of follow-up measures-For household members:-Age at enrollment: 12+ years-Significantly involved in supporting nutrition in the home including foodshopping, preparation, social support for healthy nutrition-Willing to complete some questionnaires and attend a single group session.-For all participants:-Able and willing to provide informed consentExclusion Criteria:-Unable to provide informed consent-Unable to speak, read, or understand English and/or Spanish-Active substance use or psychotic disorders that would impair participation in agroup lifestyle intervention or interfere with follow-up assessments-Lacking mailing address for delivery of food box-Planning to relocate out of area within the next 12 months-Index participant only: Pregnant or planning to become pregnant within the next 12months", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03198_AGE", "age": 19, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01384_AGE", "age": 64, "sex": "Male", "country": "United States", "bmi": 30.7, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03435", "age": 33, "sex": "Female", "country": "United States", "bmi": 33.7, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01110", "age": 24, "sex": "Male", "country": "United States", "bmi": 32.7, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03098", "age": 20, "sex": "Female", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02654", "age": 47, "sex": "Male", "country": "United States", "bmi": 43.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 80", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00310_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 40.3, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03293_AGE", "age": 7, "sex": "Male", "country": "United States", "bmi": 36.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00472", "age": 12, "sex": "Female", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03002_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 40.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00236_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 35.8, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03534", "age": 13, "sex": "Male", "country": "United States", "bmi": 34.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01712_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05225233", "url": "https://clinicaltrials.gov/ct2/show/NCT05225233", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 80, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Veteran enrolled in a MOVE! Weight Management Program (group or individual) at theMinneapolis VA Health Care System-Obese (BMI>30 or BMI>27 plus at least one weight-related comorbidity)-Adults, ages 18 years or older (up to age 80)-Able to understand English, self-consent and follow study-related procedures-Willing to use a reliable form of birth control if they are of females ofchild-bearing potentialExclusion Criteria:-History of any of the following: seizures, severe or moderate head injury, headsurgery, significant neurological disorder (significance based on PrincipalInvestigator's judgment)-Frequent severe headaches-History of scalp conditions such as eczema or seborrheic dermatitis-Metal in head (other than in mouth) including shrapnel/surgical clips/weldingfragments-Implanted medical devices (including pumps and cardiac pacemakers)-Pregnancy-Acute substance dependence or withdrawal that would affect ability to completecognitive training-Moderately severe to severe depression (as identified on PHQ-9 scale during baselinescreening)-Other psychological or medical disorders requiring inpatient treatment (asidentified during chart review)-Presence of a known metabolic or hormonal disorder (such as Cushing's, untreatedthyroid dysfunction, or uncontrolled diabetes mellitus defined as a hemoglobin A1c >8.0), or significant edema/volume overload - all of which would affect weight-Uncontrolled hypothyroidism that would affect weight", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-80"], "rationale": "Failed criteria: Age not in range 18-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02832_AGE", "age": 18, "sex": "Female", "country": "United States", "bmi": 39.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01821", "age": 38, "sex": "Male", "country": "United States", "bmi": 43.3, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00268", "age": 69, "sex": "Male", "country": "United States", "bmi": 37.3, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01875_BMI", "age": 64, "sex": "Female", "country": "United States", "bmi": 96.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03412_BMI", "age": 33, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02816", "age": 39, "sex": "Male", "country": "United States", "bmi": 26.0, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00631", "age": 35, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00064_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01603_AGE", "age": 4, "sex": "Female", "country": "United States", "bmi": 37.6, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02341_AGE", "age": 3, "sex": "Male", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00850", "age": 15, "sex": "Male", "country": "United States", "bmi": 42.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03528_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01527_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05215886", "url": "https://clinicaltrials.gov/ct2/show/NCT05215886", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Cognitive impairment/decline, memory impairment/loss, or Alzheimer's disease ordementia and bariatric surgery  Cognitive impairment/decline, memoryimpairment/loss, or Alzheimer's disease or dementia and obesity, and no bariatricsurgery historyExclusion Criteria:-Patients without a history of memory impairment/loss, bariatric surgery, or obesity-Patients outside of University of California Davis Health System-Patients unable to provide consent", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01563_BMI", "age": 15, "sex": "Male", "country": "United States", "bmi": 85.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01297", "age": 62, "sex": "Male", "country": "United States", "bmi": 37.6, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01310_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01611_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01511", "age": 14, "sex": "Female", "country": "United States", "bmi": 32.7, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01489_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 34.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02427_BMI", "age": 26, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03248", "age": 40, "sex": "Female", "country": "United States", "bmi": 38.8, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01436_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02910_AGE", "age": 57, "sex": "Female", "country": "United States", "bmi": 30.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05190666", "url": "https://clinicaltrials.gov/ct2/show/NCT05190666", "status": "Recruiting", "countries": ["United States"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:Participants must:-have a body mass index between 25-45 kg/m2-have had a knee replacement (including primary, staged or independent bilateral, orrevision) <6 months prior to baseline assessment-have a computer, tablet, or smartphone with active internet access to self-monitoronline and/or have a device or computer compatible with Fitbit-completion of baseline assessment measures (height, weight, function tests, surveys,=4 days valid of activity monitoring, and 1 day of dietary recall)-be English-speaking and able to read consent and study materials written in English-be willing to attend 4 in-person assessments.Exclusion Criteria:-have any contraindications to diet or weight loss-undergo simultaneous bilateral knee replacement or have a scheduled or anticipatedknee replacement for the contralateral knee within the next 18 months-have a mobility limiting comorbidity unrelated to knee replacement (e.g. spinalstenosis, fibromyalgia, peripheral vascular disease, stroke)-are taking anti-obesity medications-are enrolled in a formal weight loss program-had or are planning to have bariatric/gastric/lap band surgery-are planning to relocate out of the Columbia or Greenville, SC areas in the next 18months.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00264_AGE", "age": 24, "sex": "Male", "country": "United States", "bmi": 45.3, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02659_AGE", "age": 34, "sex": "Male", "country": "United States", "bmi": 35.3, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00371", "age": 22, "sex": "Female", "country": "United States", "bmi": 37.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01061_BMI", "age": 22, "sex": "Male", "country": "United States", "bmi": 19.5, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00537", "age": 43, "sex": "Male", "country": "United States", "bmi": 43.8, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02966_BMI", "age": 48, "sex": "Male", "country": "United States", "bmi": 29.8, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01078_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00236_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 35.8, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03377_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 33.6, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01227_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01328_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.7, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01340_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02053_AGE", "age": 15, "sex": "Male", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01503_BMI", "age": 13, "sex": "Male", "country": "United States", "bmi": 18.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02597_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 24.4, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05107908", "url": "https://clinicaltrials.gov/ct2/show/NCT05107908", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI of 27 or greaterExclusion Criteria:-MRI contraindications (e.g., metal or electronic devices in the body)-Pregnancy", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00023_BMI", "age": 30, "sex": "Male", "country": "United States", "bmi": 26.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03555", "age": 41, "sex": "Male", "country": "United States", "bmi": 38.6, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01890", "age": 36, "sex": "Female", "country": "United States", "bmi": 31.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00995", "age": 32, "sex": "Female", "country": "United States", "bmi": 33.4, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02961", "age": 55, "sex": "Female", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03320", "age": 22, "sex": "Male", "country": "United States", "bmi": 38.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 25.0 and 40.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02193", "age": 12, "sex": "Male", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02602_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 28.2, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03326_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00018_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00615_BMI", "age": 53, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 60"], "failed_criteria": ["BMI not in range 25.0-40.0"], "rationale": "Failed criteria: BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01487_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 42.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-60", "BMI not in range 25.0-40.0"], "rationale": "Failed criteria: Age not in range 18-60, BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00414", "age": 16, "sex": "Male", "country": "United States", "bmi": 20.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-60", "BMI not in range 25.0-40.0"], "rationale": "Failed criteria: Age not in range 18-60, BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03353", "age": 15, "sex": "Male", "country": "United States", "bmi": 38.9, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 40.0"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03615", "age": 24, "sex": "Female", "country": "United States", "bmi": 42.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 60"], "failed_criteria": ["BMI not in range 25.0-40.0"], "rationale": "Failed criteria: BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00476", "age": 7, "sex": "Female", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05119504", "url": "https://clinicaltrials.gov/show/NCT05119504", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": 25.0, "bmi_max": 40.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-60 years old,-BMI 25-40 kg/m2-insufficiently active (<60 minutes of moderate intensity activity per week).-High/low internalized weight bias-Access to personal smartphone device and willing to download free smartphone app for data collection Exclusion Criteria:-Comorbid issues that might interfere with ability to engage in physical activity-Factors that would influence ability to complete study protocol (e.g., cognitive, psychological)-medication that would affect heart rate (e.g., beta blocker),-women who are nursing or pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-60", "BMI not in range 25.0-40.0"], "rationale": "Failed criteria: Age not in range 18-60, BMI not in range 25.0-40.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01296", "age": 46, "sex": "Female", "country": "United States", "bmi": 35.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01837", "age": 36, "sex": "Female", "country": "United States", "bmi": 33.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00363_BMI", "age": 23, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00852", "age": 50, "sex": "Female", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01553_BMI", "age": 39, "sex": "Male", "country": "United States", "bmi": 26.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01010_BMI", "age": 21, "sex": "Female", "country": "United States", "bmi": 19.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00796", "age": 69, "sex": "Male", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01101", "age": 33, "sex": "Male", "country": "United States", "bmi": 37.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00142_BMI", "age": 34, "sex": "Female", "country": "United States", "bmi": 26.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03477_AGE", "age": 6, "sex": "Male", "country": "United States", "bmi": 41.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01238_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 38.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03240_AGE", "age": 4, "sex": "Female", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00583_AGE", "age": 2, "sex": "Male", "country": "United States", "bmi": 40.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00165_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 23.6, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02180_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02666_BMI", "age": 13, "sex": "Male", "country": "United States", "bmi": 84.5, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00311_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05067231", "url": "https://clinicaltrials.gov/ct2/show/NCT05067231", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age more than or equal to 18Exclusion Criteria:-Age <18, at screening-Employees or students associated with the Division of Cardiovascular Disease at UABwill not be recruited due to their vulnerable status and susceptibility to coercion.-Women who are pregnant or who can become pregnant and not practicing an acceptablemethod of birth control.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03150_AGE", "age": 6, "sex": "Female", "country": "United States", "bmi": 39.7, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 2 and 8", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03376_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 34.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 2 and 8", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02342", "age": 7, "sex": "Male", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 2 and 8", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01508_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 35.9, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 2 and 8", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02972_AGE", "age": 2, "sex": "Male", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 2 and 8", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03051_AGE", "age": 3, "sex": "Male", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 2 and 8", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01020_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 30.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01414", "age": 69, "sex": "Male", "country": "United States", "bmi": 30.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00034_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00929_AGE", "age": 44, "sex": "Male", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01703_BMI", "age": 53, "sex": "Male", "country": "United States", "bmi": 49.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01407_AGE", "age": 49, "sex": "Male", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00431_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01004", "age": 48, "sex": "Male", "country": "United States", "bmi": 34.8, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 2-8"], "rationale": "Failed criteria: Age not in range 2-8", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03212_BMI", "age": 52, "sex": "Male", "country": "United States", "bmi": 404.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05143697", "url": "https://clinicaltrials.gov/ct2/show/NCT05143697", "status": "Recruiting", "countries": ["United States"], "age_min": 2, "age_max": 8, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> 24 Eligible Intervention Clinics will provide motivational interview counseling and referrals to Wellness Coaching. Inclusion criteria:-Children age 2-8 years-Body mass index in the 85 percentile or higher Exclusion criteria:  Families that don't speak English or Spanish as a primary language", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 2-8", "BMI not in range 0-100"], "rationale": "Failed criteria: Age not in range 2-8, BMI not in range 0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00917", "age": 25, "sex": "Female", "country": "United States", "bmi": 32.7, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02363_AGE", "age": 20, "sex": "Male", "country": "United States", "bmi": 37.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03495_BMI", "age": 48, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01596", "age": 61, "sex": "Female", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01408", "age": 56, "sex": "Male", "country": "United States", "bmi": 35.2, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00703_AGE", "age": 59, "sex": "Female", "country": "United States", "bmi": 44.6, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02858_AGE", "age": 29, "sex": "Male", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03021", "age": 11, "sex": "Male", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01684_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.2, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01981_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 34.6, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03542_AGE", "age": 9, "sex": "Female", "country": "United States", "bmi": 40.3, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02768_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03458_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01900_BMI", "age": 11, "sex": "Male", "country": "United States", "bmi": 84.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04633512", "url": "https://clinicaltrials.gov/ct2/show/NCT04633512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-All patients age >= 18 years old undergoing laparoscopic or robot assisted intestinal anastomoses, or all patients age >= 18 years old who are planned for laparoscopic cholecystectomy; spoken command and literacy in the native language spoken at each participating center; ability to understand and follow study procedures; and having provided signed consent.-Diagnosis:-All patients with a clinical suspicion and diagnosis of benign or malignant, small or large bowel lesions requiring surgical resection.-All patients with clinical suspicion and diagnosis of symptomatic cholelithiasis or cholecystitis planned for cholecystectomy.-Typical imaging as per standard workup findings including US, CT and/or MRI. Plain radiographs and contrast imaging may be obtained by referring physicians and are helpful for confirming the clinical diagnosis.-Any bariatric patients undergoing gastric sleeve or bypass.-Any pediatric patient undergoing laparotomy for necrotizing enterocolitis-Location of pathology or resected segment:-Target lesions can be located in any fore-, mid- or hindgut segments requiring reconstruction and anastomoses.-Prior therapy:-Patients with prior surgery are eligible for enrollment.-Laboratory:-Hemoglobin > 9 g/dL-Platelet count =75,000/L (may receive transfusions)-Normal prothrombin time, tested prothrombin, and international normalized ratio < 1.5 x upper limit of normal (ULN) (including patients on prophylactic anticoagulation)-Renal function: Age-adjusted normal serum creatinine derived from Schwartz formula for estimating glomerular filtration rate by the Centers for Disease Control (CDC) or a creatinine clearance =60 mL/min/1.73 m2 for safe-Adequate pulmonary function: Defined as no dyspnea at rest, and a pulse oximetry >94% on room air if there is clinical indication for determination. Exclusion Criteria:-There is no exclusion criteria for ActivSightTM for gastrointestinal resection.-Patients assigned to FDA cleared ICG-based visualization are contraindicated for any chronic renal dysfunction, potential drug interaction, history of allergy to ICG or anaphylaxis, and pregnancy.-Patients eligible for cholecystectomy, exclusion criteria include known allergy to iodides; known history of cholangitis, pancreatitis, prior common bile duct injury, coagulopathy or known, preexisting liver disease; pregnancy or breast-feeding; or being of reproductive age with pregnancy possible and not ruled out.-Patients currently in any investigational agents.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02984", "age": 30, "sex": "Male", "country": "United States", "bmi": 31.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00273", "age": 33, "sex": "Male", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03359", "age": 10, "sex": "Female", "country": "United States", "bmi": 40.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00453_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01583_AGE", "age": 34, "sex": "Male", "country": "United States", "bmi": 31.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01495", "age": 7, "sex": "Female", "country": "United States", "bmi": 44.6, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01937_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00593_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 33.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02254", "age": 69, "sex": "Female", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01691", "age": 68, "sex": "Male", "country": "United States", "bmi": 43.0, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01221", "age": 6, "sex": "Female", "country": "United States", "bmi": 44.2, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02913_AGE", "age": 8, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00160", "age": 67, "sex": "Male", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04644224", "url": "https://clinicaltrials.gov/ct2/show/NCT04644224", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-DYAD: Be parent/caregiver (legal parent or custodial grandparent; male or female)and child willing to participate-DYAD: Live together in the same household-PARENT/CAREGIVER: Self-identify as a racial ethic minority (i.e., black or AfricanAmerican or Hispanic)-PARENT/CAREGIVER: Parent or caregiver age 18 through 65 years old-PARENT/CAREGIVER: Are overweight (BMI greater than or equal to 25);-PARENT/CAREGIVER: Are not currently participating in a physical activity (PA), diet,or weight management program-PARENT/CAREGIVER: Have a valid home address, telephone number, and internet access-PARENT/CAREGIVER: Enroll with a child aged 8-17 years-PARENT/CAREGIVER: Are able to speak EnglishExclusion Criteria:-PARENT/CAREGIVER: They are currently pregnant or thinking about becoming pregnantduring the study period-PARENT/CAREGIVER: They present any contraindications for exercise based on responsesto the PA Readiness Questionnaire plus (PAR-Q +)Exclusion criteria for child:1) None.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-65"], "rationale": "Failed criteria: Age not in range 10-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01802", "age": 26, "sex": "Female", "country": "United States", "bmi": 34.7, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01658_AGE", "age": 39, "sex": "Male", "country": "United States", "bmi": 34.0, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01472_BMI", "age": 32, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00785_AGE", "age": 39, "sex": "Male", "country": "United States", "bmi": 30.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02376_BMI", "age": 27, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00822", "age": 29, "sex": "Female", "country": "United States", "bmi": 33.6, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01017", "age": 23, "sex": "Male", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01309_BMI", "age": 19, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 42", "BMI between 23.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03568", "age": 13, "sex": "Female", "country": "United States", "bmi": 36.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-42", "BMI not in range 23.0-35.0"], "rationale": "Failed criteria: Age not in range 18-42, BMI not in range 23.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00964", "age": 44, "sex": "Female", "country": "United States", "bmi": 24.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 23.0 and 35.0"], "failed_criteria": ["Age not in range 18-42"], "rationale": "Failed criteria: Age not in range 18-42", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01422", "age": 46, "sex": "Male", "country": "United States", "bmi": 31.9, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 23.0 and 35.0"], "failed_criteria": ["Age not in range 18-42"], "rationale": "Failed criteria: Age not in range 18-42", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01502_BMI", "age": 10, "sex": "Male", "country": "United States", "bmi": 18.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-42", "BMI not in range 23.0-35.0"], "rationale": "Failed criteria: Age not in range 18-42, BMI not in range 23.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00337", "age": 10, "sex": "Female", "country": "United States", "bmi": 31.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 23.0 and 35.0"], "failed_criteria": ["Age not in range 18-42"], "rationale": "Failed criteria: Age not in range 18-42", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01357_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.3, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-42", "BMI not in range 23.0-35.0"], "rationale": "Failed criteria: Age not in range 18-42, BMI not in range 23.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01686_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-42", "BMI not in range 23.0-35.0"], "rationale": "Failed criteria: Age not in range 18-42, BMI not in range 23.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01669", "age": 68, "sex": "Male", "country": "United States", "bmi": 36.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04583514", "url": "https://clinicaltrials.gov/ct2/show/NCT04583514", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 42, "bmi_min": 23.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Men and pre-menopausal women-18-42 years of age-BMI 23-35 kg/m2 ( 0.5 will be accepted)-Are willing to drink deuterium-labeled water (2H2O) for 8 weeks-Are willing to be randomized to either a CTL or 30% OF group-For women, if not using pharmaceutical (hormonal) contraception (i.e. birth controlpills, vaginal ring, injections, or implant), must agree to use either a doublebarrier method as a form of birth control to prevent pregnancy (i.e. male condomwith spermicide, with or without cervical cap or diaphragm); use implants orintrauterine contraceptive devices; have a tubal ligation (surgically sterile);practice abstinence; or be in an established relationship with a vasectomized orsame sex partner during the entire duration of the study-Must be willing to adhere to all study procedures, including attendance at all studyvisits-If enrolled, agree to maintain the same level of physical activity throughout theduration of the study-Must be willing to have blood stored for future researchExclusion Criteria:-Unstable weight in the last 3 months ( ~5% weight change)-Diagnosis of Type 1 or 2 diabetes or a fasting blood glucose > 110 mg/dL-Average screening blood pressure > 140/90 mmHg-Diagnosis of major organ disease (e.g. heart, kidney, lung, thyroid, liver disease)or abnormal liver enzymes that are, in the opinion of the MI, clinically significantand represent a problem for study inclusion.-Self-reported positive test for human immunodeficiency virus, hepatitis B orhepatitis C-Any current or previous eating disorders-Chronic use of systemic glucocorticoids (steroids), systemic adrenergic-stimulatingagents, beta-blockers, antipsychotic medications, thiazolidinediones and othermedications that may cause clinically significant weight gain or loss)-Chronic use of prescription weight loss medications or over the counter weight lossmedications which, in the opinion of the MI, will impact the study-Chronic use of anti-depressant medications for less than 3 months-Chronic smokers or users of tobacco products who cannot abstain for the duration ofthe inpatient visits-Previous bariatric or other surgeries for obesity-Had cancer in the last 5 years (some skin cancers acceptable)-Pregnancy, breastfeeding, or planned pregnancy for the upcoming 6 months-Partial or full hysterectomy-PCOS-Diagnosed psychotic conditions.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-42", "BMI not in range 23.0-35.0"], "rationale": "Failed criteria: Age not in range 18-42, BMI not in range 23.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00265_BMI", "age": 37, "sex": "Female", "country": "United States", "bmi": 44.5, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02862", "age": 18, "sex": "Male", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01139", "age": 47, "sex": "Female", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00193", "age": 56, "sex": "Female", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02882", "age": 54, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00857", "age": 18, "sex": "Female", "country": "United States", "bmi": 40.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00761_BMI", "age": 42, "sex": "Male", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02186", "age": 53, "sex": "Female", "country": "United States", "bmi": 41.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 35.0 and 55.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03089_AGE", "age": 13, "sex": "Male", "country": "United States", "bmi": 35.9, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 55.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00351", "age": 43, "sex": "Male", "country": "United States", "bmi": 31.6, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 35.0-55.0"], "rationale": "Failed criteria: BMI not in range 35.0-55.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01216", "age": 66, "sex": "Female", "country": "United States", "bmi": 39.9, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 55.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03472", "age": 16, "sex": "Male", "country": "United States", "bmi": 42.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 55.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03415", "age": 32, "sex": "Male", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 35.0-55.0"], "rationale": "Failed criteria: BMI not in range 35.0-55.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00017", "age": 4, "sex": "Male", "country": "United States", "bmi": 30.8, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-65", "BMI not in range 35.0-55.0"], "rationale": "Failed criteria: Age not in range 18-65, BMI not in range 35.0-55.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02670", "age": 13, "sex": "Male", "country": "United States", "bmi": 33.8, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-65", "BMI not in range 35.0-55.0"], "rationale": "Failed criteria: Age not in range 18-65, BMI not in range 35.0-55.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00402", "age": 42, "sex": "Female", "country": "United States", "bmi": 31.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 35.0-55.0"], "rationale": "Failed criteria: BMI not in range 35.0-55.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00389_BMI", "age": 65, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 35.0-55.0"], "rationale": "Failed criteria: BMI not in range 35.0-55.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03529_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04350892", "url": "https://clinicaltrials.gov/ct2/show/NCT04350892", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 35.0, "bmi_max": 55.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-18-65 years old-BMI 35-55Exclusion Criteria:-No clinically significant medical conditions-No use of tobacco-No alcohol or drug abuse-No recent weight change (+/-5%) within prior 6 months-No medications that may affect body weight or blood glucose-No diabetes medications, beta-blockers, opiates or glucocorticoids-No pregnancy, breastfeeding, or planning to become pregnant during the study (dietgroup only)-No lactose intolerance", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 55.0"], "failed_criteria": ["Age not in range 18-65"], "rationale": "Failed criteria: Age not in range 18-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01202", "age": 18, "sex": "Female", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01946", "age": 20, "sex": "Female", "country": "United States", "bmi": 31.8, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02499", "age": 28, "sex": "Male", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02981", "age": 32, "sex": "Female", "country": "United States", "bmi": 41.8, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02258", "age": 22, "sex": "Female", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00193_BMI", "age": 56, "sex": "Female", "country": "United States", "bmi": 41.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00962_BMI", "age": 47, "sex": "Male", "country": "United States", "bmi": 17.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00852_AGE", "age": 49, "sex": "Female", "country": "United States", "bmi": 34.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 99", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00995_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 33.4, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02636_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 19.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02562_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.1, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01073_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01293_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 42.4, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02313_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.5, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04297592", "url": "https://clinicaltrials.gov/ct2/show/NCT04297592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 99, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patient is a candidate for elective, primary total hip arthroplasties (THA) or totalknee arthroplasties (TKA).-Patient is considered high-risk for developing Periprosthetic joint infections (PJI)based on having at least one of the following criteria:-Body mass index (BMI) > 35 kg/m^2;-Diagnosis of diabetes mellitus;-Active tobacco smoker;-Chronic kidney disease;-Autoimmune disease;-Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) ormethicillin-sensitive Staphylococcus aureus (MSSA).Exclusion Criteria:-Inability to consume oral antibiotics.-Allergy to antibiotic alternatives in the protocol.-History of clostridium difficile colitis.-Revision hip or knee arthroplasty procedure.-Non-elective surgery.-Hemiarthroplasty.-Unicompartmental knee arthroplasty.-Simultaneous bilateral THA or TKA.-Will have subsequent THA or TKA within 12 weeks of the index study procedure.-Pregnant.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-99"], "rationale": "Failed criteria: Age not in range 18-99", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00695", "age": 30, "sex": "Female", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01723", "age": 52, "sex": "Male", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02672_AGE", "age": 20, "sex": "Male", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02081", "age": 54, "sex": "Male", "country": "United States", "bmi": 33.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01724", "age": 44, "sex": "Male", "country": "United States", "bmi": 31.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01673", "age": 53, "sex": "Female", "country": "United States", "bmi": 41.2, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03365_BMI", "age": 56, "sex": "Female", "country": "United States", "bmi": 26.5, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02629", "age": 39, "sex": "Female", "country": "United States", "bmi": 40.3, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 20 and 65", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01689", "age": 19, "sex": "Female", "country": "United States", "bmi": 40.0, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02501_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 25.7, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03047_AGE", "age": 12, "sex": "Male", "country": "United States", "bmi": 34.8, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01418_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02254_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01203_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.4, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04225507", "url": "https://clinicaltrials.gov/ct2/show/NCT04225507", "status": "Recruiting", "countries": ["United States"], "age_min": 20, "age_max": 65, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight or obese-Prediabetes-Sleep apneaExclusion Criteria:-Diabetic-enrolled in a formal weight loss program-Any underlying disease likely to limit life span and/or increase risk ofinterventions", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 20-65"], "rationale": "Failed criteria: Age not in range 20-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02547", "age": 52, "sex": "Male", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02746", "age": 34, "sex": "Female", "country": "United States", "bmi": 41.2, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01086", "age": 50, "sex": "Male", "country": "United States", "bmi": 35.0, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01051", "age": 35, "sex": "Female", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02837_AGE", "age": 20, "sex": "Female", "country": "United States", "bmi": 42.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02816", "age": 39, "sex": "Male", "country": "United States", "bmi": 26.0, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 25.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02263_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01507", "age": 11, "sex": "Male", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03398_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.2, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00412", "age": 17, "sex": "Female", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-120", "BMI not in range 25.0-100"], "rationale": "Failed criteria: Age not in range 18-120, BMI not in range 25.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02231_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00646", "age": 12, "sex": "Female", "country": "United States", "bmi": 35.5, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04228978", "url": "https://clinicaltrials.gov/ct2/show/NCT04228978", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": 25.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria are a) presence of PAD; b) BMI> 25 kg/m2; c) Age >= 18. The diagnosisof PAD will be based on the following. First, an ankle brachial index (ABI) value <=0.90, which is a well-accepted standard for diagnosing PAD. People with a toe brachialindex of <=0.70, performed at the study visit, will be eligible. Second, people with anABI of >0.90 and <=1.00 who experience a 20% or greater drop in ABI in either leg afterthe heel-rise test will also be included. Third, potential participants with an ABI >0.90 who provide vascular laboratory evidence or angiographic evidence of PAD will beincluded. Prior vascular laboratory evidence consists of objective evidence of PADincluding toe brachial index (TBI) < 0.70, Duplex measure showing 70% stenosis orgreater, a post-exercise ABI drop in either leg of 20% or greater, or ABI values <= 0.90.Angiographic evidence of PAD consists of a stenosis of 70% or greater in a lowerextremity artery. Fourth, people with a history of lower extremity revascularization whodo not meet the criterion above and have an ABI > 0.90 with a 20% or higher drop in ABIafter an exercise test will be eligible if they have symptomatic PAD. Symptomatic PADwill be defined as leg symptoms associated with exertion that resolved within 10 minutesof rest. The presence of symptomatic PAD will be determined based on the claudicationquestionnaire, the six-minute walk, or principal investigator interview/discussion withthe potential participant. The post-exercise ABI drop will be measured by obtaining anABI, having the participant exercise, and then immediately repeating the ABI. Theexercise may consist of either the six-minute walk test or the heel-rise test. Theheel-rise test consists of 50 heel rises at a rate of one per second. From the beginningof the trial until early 2023, we used the BMI inclusion criterion of > 28 kg/m2 becauseoverweight and obesity are defined as a BMI of 25 to 29 kg/m2 and > 30 kg/m2,respectively, and because in our PAD cohorts, those with BMI > 28 kg/m2 havesignificantly greater functional impairment and faster functional decline than those withBMI of 20-28 kg/m2. In order to increase the rate of recruitment, on 1/19/2022,investigators reduced the BMI inclusion criterion to > 25 kg/ m2. People with BMI above25 are overweight or obese and therefore are expected to benefit from the healthylifestyle intervention.Exclusion Criteria:1. Above or below knee amputation, critical limb ischemia, or wheelchair confinement.2. Walking is limited by a condition other than PAD.3. Failure to complete the study run-in, defined as not entering at least 800 Kcal ofconsumed calories per day for at least five days during the 14-day run-in*.4. Major surgery, coronary or leg revascularization in the past 3 months or anticipatedin the next year.5. Experienced a heart attack or stroke in the past 3 months.6. Major medical illness including lung disease requiring oxygen or life-threateningillness, Parkinson's disease, a life-threatening illness with life expectancy lessthan six months, or cancer requiring treatment in the previous two years. [NOTE:potential participants may still qualify if they have had treatment for an earlystage cancer in the past two years and the prognosis is excellent.7. Mini-Mental Status Examination (MMSE) score < 23, dementia and substance abuse.Potential participants with an MMSE score of less than 23 may be eligible if theprincipal investigator determines that their lower score is due to reasons otherthan poor cognition. Other potential reasons for lower scores include poor literacyor that English is not their first language.8. History of being treated for new onset or an acute episode of schizophrenia orpsychosis in the past 6 months.9. Hospitalization for a psychiatric disorder in the past 6 months. 10. BMI > 45 kg/m2 11. History of a significant eating disorder that has been active within the past 5years or any weight loss treatment in the past 6 months. Weight loss treatmentincludes weight watchers, any history of weight loss surgery, and using weight lossmedications now or in the past six months. 12. Weight gain or loss of more than 25 pounds in the past six months 13. Potential participants unwilling/unable to use a smart phone and unwilling to attendweekly study sessions. 14. Excessive alcohol use, defined as >14 drinks/week in men and > 10 alcoholicdrinks/week in women. 15. Current ulcer on bottom of foot 16. Current participation in supervised treadmill exercise, participation in supervisedtreadmill exercise in the past three months, or planning to participate insupervised treadmill exercise in the next year 17. Increase in angina or angina at rest. Potential participants may become eligiblefollowing an abnormal baseline treadmill stress test if they have evidence of anabsence of coronary ischemia based on testing with their own physician. 18. Non-English speaking 19. Visual impairment that limits walking ability 20. Currently walking regularly for exercise at a level comparable to the amount ofexercise prescribed in the intervention 21. Participation in or completion of a clinical trial in the previous three months.[NOTE: after completing a stem cell or gene therapy intervention, participants willbecome eligible after the final study follow-up visit of the stem cell or genetherapy study so long as at least six months have passed since the finalintervention administration. After completing a supplement or drug therapy (otherthan stem cell or gene therapy), participants will be eligible after the final studyfollow-up visit as long as at least three months have passed since the finalintervention of the trial.] 22. In addition to the above criteria, investigator discretion will be used to determineif the trial is unsafe or not a good fit for the potential participant-The run-in will also be used to assist participants with learning the app.However, they must demonstrate ability to enter at least 800 Kcal per day forat least five days of the run-in.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02790_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02042_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03558", "age": 23, "sex": "Female", "country": "United States", "bmi": 34.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01922_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02561", "age": 22, "sex": "Male", "country": "United States", "bmi": 38.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00934", "age": 47, "sex": "Female", "country": "United States", "bmi": 38.3, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02830_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 29.7, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01109_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.6, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02224", "age": 38, "sex": "Female", "country": "United States", "bmi": 32.1, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 10 and 80", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00850_AGE", "age": 5, "sex": "Male", "country": "United States", "bmi": 42.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01270_AGE", "age": 2, "sex": "Male", "country": "United States", "bmi": 33.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02328_AGE", "age": 2, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02342", "age": 7, "sex": "Male", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01507_AGE", "age": 7, "sex": "Male", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00477_AGE", "age": 5, "sex": "Male", "country": "United States", "bmi": 35.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02005_AGE", "age": 8, "sex": "Male", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00594_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 41.8, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT04013282", "url": "https://clinicaltrials.gov/ct2/show/NCT04013282", "status": "Recruiting", "countries": ["United States"], "age_min": 10, "age_max": 80, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Patients with the symptoms suggestive of autonomic and/or enteric disorders.Exclusion Criteria:-Anatomic obstruction of the GI tract-Pregnancy-Inability of patient or guardian to sign informed consent, if needed-Psychiatric disorders precluding assessment and treatment of the patient's GIcondition.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 10-80"], "rationale": "Failed criteria: Age not in range 10-80", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00791", "age": 43, "sex": "Male", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 40.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02258", "age": 22, "sex": "Female", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 40.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02184_AGE", "age": 39, "sex": "Male", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 40.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02889", "age": 31, "sex": "Male", "country": "United States", "bmi": 43.8, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 40.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00203", "age": 34, "sex": "Female", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 40.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00182", "age": 22, "sex": "Male", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 65", "BMI between 40.0 and 50.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02135", "age": 65, "sex": "Female", "country": "United States", "bmi": 28.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 40.0-50.0"], "rationale": "Failed criteria: BMI not in range 40.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02293_BMI", "age": 38, "sex": "Male", "country": "United States", "bmi": 18.0, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 40.0-50.0"], "rationale": "Failed criteria: BMI not in range 40.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02973_AGE", "age": 2, "sex": "Female", "country": "United States", "bmi": 39.3, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-65", "BMI not in range 40.0-50.0"], "rationale": "Failed criteria: Age not in range 18-65, BMI not in range 40.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03210_AGE", "age": 24, "sex": "Female", "country": "United States", "bmi": 31.6, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 40.0-50.0"], "rationale": "Failed criteria: BMI not in range 40.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00226", "age": 65, "sex": "Male", "country": "United States", "bmi": 34.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 40.0-50.0"], "rationale": "Failed criteria: BMI not in range 40.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00245", "age": 22, "sex": "Female", "country": "United States", "bmi": 37.5, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 65"], "failed_criteria": ["BMI not in range 40.0-50.0"], "rationale": "Failed criteria: BMI not in range 40.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01893", "age": 12, "sex": "Male", "country": "United States", "bmi": 30.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03868592", "url": "https://clinicaltrials.gov/ct2/show/NCT03868592", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 65, "bmi_min": 40.0, "bmi_max": 50.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI 40 - 50 kg/m2.-Mo active physical illness that would interfere with mobility or weight loss afterbariatric surgeryExclusion Criteria:-Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose =126 mg/dL-Active coronary artery disease-Participation in structured exercise (>2 times per week for 30 minutes or longer)-Smoking-Medications known to affect adipose tissue metabolism (e.g., beta blockers,corticosteroids)-Renal insufficiency (serum creatinine > 1.5mg/dl)-Chronic active liver disease (Bilirubin > 17mmol/L, AST > 144 IU/L, or ALT>165IU/L)-Pregnancy or breastfeeding.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 18-65", "BMI not in range 40.0-50.0"], "rationale": "Failed criteria: Age not in range 18-65, BMI not in range 40.0-50.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01329", "age": 54, "sex": "Male", "country": "United States", "bmi": 38.6, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02955_BMI", "age": 56, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00808", "age": 55, "sex": "Female", "country": "United States", "bmi": 38.3, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00876", "age": 19, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02403", "age": 44, "sex": "Male", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03139_AGE", "age": 24, "sex": "Female", "country": "United States", "bmi": 40.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00804", "age": 36, "sex": "Female", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 60", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01548", "age": 61, "sex": "Male", "country": "United States", "bmi": 33.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03611", "age": 70, "sex": "Female", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01787_BMI", "age": 63, "sex": "Male", "country": "United States", "bmi": 49.5, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02280_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 33.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02740_AGE", "age": 7, "sex": "Female", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02722_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00930", "age": 67, "sex": "Male", "country": "United States", "bmi": 38.3, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01716_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03840733", "url": "https://clinicaltrials.gov/ct2/show/NCT03840733", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 60, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)-Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)-Capable and willing to give informed consent-Possess a smartphone to install and utilize the meal timing application-Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days-Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria:-Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)-New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)-Women who became pregnant after completing the Parent Trial-Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-60"], "rationale": "Failed criteria: Age not in range 18-60", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02720", "age": 53, "sex": "Female", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02993", "age": 24, "sex": "Female", "country": "United States", "bmi": 36.6, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03006", "age": 58, "sex": "Male", "country": "United States", "bmi": 33.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02504", "age": 62, "sex": "Female", "country": "United States", "bmi": 43.0, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03280", "age": 27, "sex": "Male", "country": "United States", "bmi": 37.8, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03013_AGE", "age": 6, "sex": "Male", "country": "United States", "bmi": 43.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03002_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 40.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02229_AGE", "age": 10, "sex": "Female", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00254", "age": 15, "sex": "Female", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01927_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03947697", "url": "https://clinicaltrials.gov/ct2/show/NCT03947697", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Overweight/Obese (BMI =25)-Sedentary Lifestyle: Physical Activity Level<1.4-Less than 150min/week of structured ExerciseExclusion Criteria:-Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications-Excessive alcohol, drug abuse, smoking-Pregnant Women-Unwilling to adhere to the study Intervention", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00625_AGE", "age": 21, "sex": "Female", "country": "United States", "bmi": 37.1, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03196_BMI", "age": 60, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03096", "age": 67, "sex": "Female", "country": "United States", "bmi": 34.8, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02754_AGE", "age": 12, "sex": "Female", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01854", "age": 24, "sex": "Female", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00277_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.0, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01451_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 32.2, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01923", "age": 47, "sex": "Male", "country": "United States", "bmi": 34.8, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00383_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 42.3, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "EUCTR2017-003380-35-FI", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003380-35", "status": "Not Recruiting", "countries": ["Russian Federation", "United States", "Malaysia", "Thailand", "Portugal", "Latvia", "Netherlands", "Austria", "Sweden", "Ireland", "Brazil", "Algeria", "Serbia", "Bulgaria", "Croatia", "Colombia", "Argentina", "Romania", "Hungary", "Japan", "Ukraine", "United Kingdom", "India", "Canada", "Czech Republic", "Turkey", "Belgium", "European Union", "Norway", "Finland", "Taiwan", "Denmark", "Mexico", "South Africa", "Italy", "Israel", "Australia"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion criteria: <br>1. Male or female, age equal to or above 45 years at the time of signing informed consent <br>2. Body mass index (BMI) equal to or above 27 kg/sqm<br>3. Have established CV disease as evidenced by at least one of the following:<br>- prior myocardial infarction<br>- prior stroke (ischemic or haemorrhagic stroke) or<br>- symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 0.85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease<br>Are the trial subjects under 18? no<br>Number of subjects for this age range: <br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 11375<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 6125<br>", "raw_exclusion": "Exclusion criteria: <br>1. Any of the following: myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within the past 60 days prior to the day of screening<br>2. HbA1c equal to or above 48 mmol/mol (6.5 %) as measured by the central laboratory at screening<br>3. History of type 1 or type 2 diabetes (history of gestational diabetes is allowed)<br>"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00124", "age": 38, "sex": "Male", "country": "United States", "bmi": 30.9, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 35 and 65", "BMI between 25.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02583", "age": 50, "sex": "Female", "country": "United States", "bmi": 31.2, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 35 and 65", "BMI between 25.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02009", "age": 54, "sex": "Male", "country": "United States", "bmi": 27.5, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 35 and 65", "BMI between 25.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02282", "age": 51, "sex": "Female", "country": "United States", "bmi": 33.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 35 and 65", "BMI between 25.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03512", "age": 41, "sex": "Male", "country": "United States", "bmi": 33.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 35 and 65", "BMI between 25.0 and 35.0"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01078_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 35-65", "BMI not in range 25.0-35.0"], "rationale": "Failed criteria: Age not in range 35-65, BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02971_AGE", "age": 2, "sex": "Male", "country": "United States", "bmi": 43.5, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 35-65", "BMI not in range 25.0-35.0"], "rationale": "Failed criteria: Age not in range 35-65, BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02815_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 35-65", "BMI not in range 25.0-35.0"], "rationale": "Failed criteria: Age not in range 35-65, BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03367_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 35-65", "BMI not in range 25.0-35.0"], "rationale": "Failed criteria: Age not in range 35-65, BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00830", "age": 16, "sex": "Male", "country": "United States", "bmi": 32.7, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 35.0"], "failed_criteria": ["Age not in range 35-65"], "rationale": "Failed criteria: Age not in range 35-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00804_AGE", "age": 24, "sex": "Female", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 25.0 and 35.0"], "failed_criteria": ["Age not in range 35-65"], "rationale": "Failed criteria: Age not in range 35-65", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00855", "age": 51, "sex": "Male", "country": "United States", "bmi": 36.4, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 35 and 65"], "failed_criteria": ["BMI not in range 25.0-35.0"], "rationale": "Failed criteria: BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00914", "age": 57, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 35 and 65"], "failed_criteria": ["BMI not in range 25.0-35.0"], "rationale": "Failed criteria: BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00106_BMI", "age": 35, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 35 and 65"], "failed_criteria": ["BMI not in range 25.0-35.0"], "rationale": "Failed criteria: BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00006", "age": 58, "sex": "Male", "country": "United States", "bmi": 35.6, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT05165706", "url": "https://clinicaltrials.gov/ct2/show/NCT05165706", "status": "Recruiting", "countries": ["United States"], "age_min": 35, "age_max": 65, "bmi_min": 25.0, "bmi_max": 35.0, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Age 35-65-BMI 25-35 kg/m2-Stable body weight-NondiabeticExclusion Criteria:Patients with;-diabetes-major organ disease-history of liposuction or bariatric surgery-active eating or psychiatric disorder-pregnancy or lactation, heavy alcohol use-recent change in weight (over the past 12 weeks)-use of weight loss medication, statins, or oral steroidsClinical screening exclusions;-hematocrit < 33%-fasting glucose >/= 126 mg/dL-blood pressure >160/100 mmHg", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 35 and 65"], "failed_criteria": ["BMI not in range 25.0-35.0"], "rationale": "Failed criteria: BMI not in range 25.0-35.0", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02019", "age": 21, "sex": "Female", "country": "United States", "bmi": 38.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02015", "age": 32, "sex": "Female", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00916", "age": 35, "sex": "Female", "country": "United States", "bmi": 37.9, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02423_BMI", "age": 41, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00786", "age": 29, "sex": "Male", "country": "United States", "bmi": 36.6, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01733_BMI", "age": 32, "sex": "Male", "country": "United States", "bmi": 24.5, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 50", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00836_AGE", "age": 14, "sex": "Male", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00320", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03385_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00605_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 33.5, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01394_BMI", "age": 60, "sex": "Female", "country": "United States", "bmi": 18.0, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01047_BMI", "age": 65, "sex": "Female", "country": "United States", "bmi": 39.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00722_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.2, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03527420", "url": "https://clinicaltrials.gov/ct2/show/NCT03527420", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 50, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-BMI = 35 kg/m2-Between ages 18-50 years-Not pregnant-Approved for a bariatric surgeryExclusion Criteria:-To avoid confounding from other inflammatory conditions individuals with currentcancer, heart, kidney or liver disease, gallbladder disease or acute or chronicinflammatory diseases (including rheumatoid arthritis, lupus and other autoimmunediseases and genetic diseases) will be excluded-Pregnant women will be excluded, as they will not be eligible for bariatric surgery-Current smokers-Currently abusing alcohol or drugs", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-50"], "rationale": "Failed criteria: Age not in range 18-50", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03417", "age": 25, "sex": "Male", "country": "United States", "bmi": 37.1, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02092_BMI", "age": 48, "sex": "Male", "country": "United States", "bmi": 23.5, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02803", "age": 49, "sex": "Male", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01852", "age": 40, "sex": "Female", "country": "United States", "bmi": 32.6, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01022", "age": 57, "sex": "Female", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00067_BMI", "age": 31, "sex": "Female", "country": "United States", "bmi": 24.4, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 70", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01728_AGE", "age": 9, "sex": "Female", "country": "United States", "bmi": 36.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01438_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.6, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00834", "age": 15, "sex": "Male", "country": "United States", "bmi": 42.9, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03417_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.1, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03575_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.4, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03488212", "url": "https://clinicaltrials.gov/show/NCT03488212", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 70, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Body mass index (BMI) between 25-45 kg/meters-squared-one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension) Exclusion Criteria:-currently in another active weight loss program-taking weight loss medication-currently pregnant, lactating-<6 months post-partum-plan to become pregnant during the next 12 months-a medical condition that would affect the safety of participating in unsupervised physical activity-inability to walk 2 blocks without stopping", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-70"], "rationale": "Failed criteria: Age not in range 18-70", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02370", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 14 and 17", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01995_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.2, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 14 and 17", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02077_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 14 and 17", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01054_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.3, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 14 and 17", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03040_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 41.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 14 and 17", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01416_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.7, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 14 and 17", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02665_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 14 and 17"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00586_AGE", "age": 49, "sex": "Male", "country": "United States", "bmi": 37.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 100"], "failed_criteria": ["Age not in range 14-17"], "rationale": "Failed criteria: Age not in range 14-17", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00468_AGE", "age": 3, "sex": "Female", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 100"], "failed_criteria": ["Age not in range 14-17"], "rationale": "Failed criteria: Age not in range 14-17", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02451_AGE", "age": 23, "sex": "Female", "country": "United States", "bmi": 39.6, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 100"], "failed_criteria": ["Age not in range 14-17"], "rationale": "Failed criteria: Age not in range 14-17", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01611", "age": 43, "sex": "Female", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": [], "failed_criteria": ["Age not in range 14-17", "BMI not in range 35.0-100"], "rationale": "Failed criteria: Age not in range 14-17, BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00455", "age": 42, "sex": "Male", "country": "United States", "bmi": 40.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03233048", "url": "https://clinicaltrials.gov/show/NCT03233048", "status": "Recruiting", "countries": ["United States"], "age_min": 14, "age_max": 17, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria: BMI>35 kilogram per square meter (kg/m2) with one of the following severe comorbidities, both for at least 2 years:1. Type 2 diabetes mellitus2. Moderate-to-severe sleep apnea3. Pseudotumor cerebri4. Nonalcoholic Steatohepatitis (NASH) based on fatty infiltration of the liver with transaminitis that cannot be explained by other liver disease Or, BMI>40 kilogram per square meter (kg/m2) with two or more of the following mild comorbidities, all for at least 2 years:1. Hypertension2. Dyslipidemia3. Mild obstructive sleep apnea4. Chronic venous insufficiency5. Panniculitis6. Urinary incontinence7. Nonalcoholic Steatohepatitis (NASH)8. Gastroesophageal reflux disease (GERD)9. Arthropathies related to weight In addition, all of the following inclusion criteria must be met. The subject must have:1. attained approximately 95% of adult stature, as demonstrated by Tanner Stage IV or more and growth charts demonstrating the taper/plateau of height as a marker for achieving 95% of the subject's adult stature. Height will be measured by trained staff to the nearest 0.1 cm using a stadiometer attached to a wall and documented in the subject's electronic medical record (EMR). In the absence of previous growth charts, skeletal maturity will be documented by a bone age of at least 13 years in girls and 15 years in boys; and2. failed to attain a healthy weight with at least one experience with medically supervised lifestyle changes, including physical activity and dietary interventions, which will be clearly documented in the subject's medical record, and3. demonstrated commitment to psychological evaluation perioperatively, in which the pediatric psychologist with expertise in childhood obesity must confirm that the subject has the maturity and stable psychosocial environment necessary for this research study and has validated the Center for Epidemiology Study Depression (CES-D) scale and Spence Children's Anxiety Scale (SCAS) surveys completed by the subject, and4. agreed to avoid pregnancy for 1 year after intragastric balloon (IGB) placement through abstinence or approved contraception (female subjects only), and5. agreed to adhere to nutritional guidelines after intragastric balloon (IGB) placement, as provided by weight management clinic dietitian, and6. decisional capacity and desire to provide informed assent in conjunction with parent/guardian consent, and willingness to comply with all study requirements, and7. hypertension stage I: systolic blood pressure and/or diastolic blood pressure = 95th percentile, OR high normal blood pressure between the 90th and 95th percentile. Exclusion Criteria: Subjects will be excluded if:1. they are pregnant or breastfeeding, or2. there is any other disease, physical examination finding, or clinical laboratory result that provides a reasonable suspicion of a disease or condition that contraindicates the use of the investigational device or that may affect the interpretation of the results or render the subject at high risk for treatment complications, or3. there is alcohol, tobacco, or substance use by the subject, or4. in the opinion of the principal investigator (PI) and/or co-investigators, subject or parent/guardian may be non-compliant with study schedules or procedures, or5. there are any endoscopic contraindications, including large hiatal hernia (= 2 cm), esophagitis of any degree, erosive gastritis, or ulceration of the stomach or duodenum, or6. Helicobacter pylori (H. pylori) is detected via a fecal antigen study prior to initial endoscopic assessment (sensitivity > 96.8%); once treated, a repeat fecal antigen must be performed to document eradication prior to the first endoscopic approach for balloon placement, or7. they have hypertension stage II > 99th percentile, unless they had a complete workup to exclude secondary etiologies other than being overweight, or8. Gastroesophageal reflux disease (GERD) subjects are on more than one medication or have a history of erosive esophagitis due to gastroesophageal reflux disease (GERD), or9. they have dyslipidemia, if part of hereditary metabolic syndrome or genetic disorder, or10. they have any gastrointestinal disease that can result in stomach ulcerations, such as Crohn's disease, celiac disease, eosinophilic esophagitis, acute or chronic pancreatitis or gastrinoma, or11. they have any endocrine disorders that affect metabolic status of the subjects, such as hypo/hyperthyroidism, type 1 diabetes, Cushing's disease, or adrenal insufficiency, as documented in the electronic medical record (EMR) through an evaluation by the pediatric endocrinologist who will order additional testing if needed, or12. they have prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive peritonitis or known abdominal adhesions and/or history of abdominal and/or pelvic surgery which may cause adhesions (except one of the following: caesarean section, diagnostic laparoscopy, laparoscopic appendectomy, laparoscopic cholecystectomy performed 12 or more months prior to balloon implantation), or13. they have prior open or laparoscopic bariatric surgery, or14. they have prior surgery of any kind on the esophagus, stomach or any type of hiatal hernia surgery, or15. they have any inflammatory disease of the gastrointestinal tract including esophagitis, Barrett's esophagus, cancer or specific inflammation such as Crohn's disease, or16. they have potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses, or,17. they have a gastric mass, or18. they have acid reflux symptoms to any degree that require more than one medication for symptom control, or19. they have a structural abnormality in the esophagus or pharynx such as a stricture or diverticulum that could impede passage of the balloon alongside the endoscope, or20. they have achalasia or any other severe esophageal motility disorder that may pose a safety risk during the removal of the device, or21. they have severe coagulopathy, or22. they have poorly controlled diabetes, defined as having", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 100"], "failed_criteria": ["Age not in range 14-17"], "rationale": "Failed criteria: Age not in range 14-17", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01797", "age": 68, "sex": "Male", "country": "United States", "bmi": 42.5, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00359", "age": 27, "sex": "Female", "country": "United States", "bmi": 36.0, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01557", "age": 44, "sex": "Female", "country": "United States", "bmi": 33.7, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00146_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.4, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02968", "age": 28, "sex": "Male", "country": "United States", "bmi": 34.6, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03357", "age": 8, "sex": "Female", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02614", "age": 14, "sex": "Female", "country": "United States", "bmi": 35.7, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03064", "age": 41, "sex": "Male", "country": "United States", "bmi": 41.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "EUCTR2017-000387-14-GB", "url": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000387-14", "status": "Authorised", "countries": ["United States", "France", "Greece", "Canada", "Spain", "Israel", "Netherlands", "Germany", "United Kingdom"], "age_min": null, "age_max": null, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": ["psychiatric", "surgery"], "raw_inclusion": "Inclusion criteria: <br>\t1. Patients with the following genotypes and/or clinical assessment: <br> a. POMC/PCSK1/LEPR heterozygous <br>\tb. POMC/PCSK1/LEPR compound heterozygous (two different mutations in gene) or homozygous deficiency obesity <br>\tc. POMC/PCSK1/LEPR composite heterozygous (two or more mutations in two or more genes) deficiency obesity <br>\td. Smith-Magenis Syndrome (SMS) <br>\te. SH2B1 deficiency obesity <br>\tf. Chromosomal rearrangement of the 16p11.2 locus causing obesity <br>\tg. CPE compound heterozygous or homozygous deficiency obesity <br>\th. Leptin deficiency obesity with loss of response to metreleptin <br>\ti. SRC1 deficiency obesity <br>\tj. MC4R deficiency obesity <br>\t<br>Note: The specific genotype for all patients must be reviewed by the Sponsor prior to study enrollment to confirm that the patient meets Inclusion Criterion #1. In addition, enrollment of patients in some subgroups may be prioritized by the Sponsor in order to ensure enrollment of patients with (1) well described, loss-of-function genetic mutations, (2) a variety of genetic variants, or (3) genetic variants likely to respond to setmelanotide. <br>2. Age 6 years and above. <br>3. Obese, defined as Body Mass Index (BMI) = 30 kg/m2 for patients =16 years of age or BMI = 95th percentile for age and gender for patients 6 up to 16 years of age. <br>4. Study participant and/or parent or guardian is able to communicate well with the Investigator, to understand and comply with the requirements of the study, and is able to understand and sign the written informed consent/assent. <br>5. Female participants of child-bearing potential must be confirmed non-pregnant, and agree to use contraception as outlined in the protocol. Female participants of non-childbearing potential, defined as surgically sterile (status post hysterectomy, bilateral oophorectomy, or bilateral tubal ligation), post-menopausal for at least 12 months (and confirmed with a screening Follicle-Stimulating Hormone [FSH] level in the post-menopausal lab range), and failure to have achieved menarche, do not require contraception during the study. <br><br>6. Male participants with female partners of childbearing potential must agree to a double-barrier method if they become sexually active during the study. Male patients must not donate sperm during and for 90 days following their participation in the study. <br><br>Are the trial subjects under 18? yes<br>Number of subjects for this age range: 48<br>F.1.2 Adults (18-64 years) yes<br>F.1.2.1 Number of subjects for this age range 86<br>F.1.3 Elderly (>=65 years) yes<br>F.1.3.1 Number of subjects for this age range 9<br>", "raw_exclusion": "Exclusion criteria: <br>1. Recent intensive (within 2 months) diet and/or exercise regimen with or without the use of weight loss agents including herbal medications that has resulted in > 2% weight loss. <br>2. Use of any medication that is approved to treat obesity within three months of first dose of study drug (e.g., orlistat, lorcaserin, phentermine-topiramate, naltrexone-bupropion). Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to a daily dose of 1.8 mg) as long as (1) is it not being prescribed for the treatment of obesity, (2) the dose has been stable for at least three months prior to enrollment, (3) the patient has not experienced weight loss during the previous three months, AND (4) the patient intends to keep the dose stable throughout the course of the study. <br>3. Gastric bypass surgery within the previous six months or any prior gastric bypass surgery resulting in >10% weight loss durably maintained from the baseline pre-operative weight with no evidence of weight regain. Specifically, patients may be considered if surgery was not successful, or resulted in <10% weight loss compared to pre-operative baseline weight or clear evidence of weight regain after an initial response to bariatric surgery. All patients with a history of bariatric surgery must be discussed with and receive approval from the Sponsor prior to enrollment. <br>4. Diagnosis of schizophrenia, bipolar disorder, personality disorder or other psychiatric disorder(s) that the Investigator believes will interfere significantly with study compliance. Neurocognitive disorders affecting ability to consent will not be disqualifying as long as an appropriate guardian able to give consent has been appointed. <br>5. A PHQ-9 score of = 15 or any suicidal ideation of type 4 or 5 on the C-SSRS during Screening, any lifetime history of a suicide attempt, or any suicidal behavior in the last month. Note: Patients who are unable to complete the PHQ-9 or C-SSRS due to significant neurocognitive defects may be allowed to enroll in the study, as long as in the opinion of the Primary Investigator there are no clinical signs or symptoms of suicidal behavior. <br>6. Current, clinically significant pulmonary, cardiac, or oncologic disease considered severe enough to interfere with the study and/or confound the results. Any patient with a potentially clinically significant disease should be reviewed with the Sponsor to determine eligibility. <br>7. HbA1c >9.0% at Screening <br><br>8. History of significant liver disease or abnormal liver tests on Screening (i.e. > 1.5 x upper limit of normal [ULN] for alanine transaminase [ALT], aspartate transaminase [AST], alkaline phosphatase, or serum bilirubin ). Note: Patients entering the study with SRC1 haploinsufficiency obesity must be evaluated during the Screening Period for hepatic fibrosis by appropriate imaging techniques (e.g., transient elastography or magnetic resonance elastography). Any patient with moderate or greater fibrosis (e.g., the equivalent of a METAVIR score = 2) will be excluded from the study. Note: A patient with a diagnosis of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) may be allowed to enroll in the study, after consultation with the Sponsor. Other significant liver disease, such as cirrhosis, are exclusionary. <br><br>9. Glomerular filtration rate (GFR) <30 mL/min at Screening. <br>10. History or close family history (pare"}}, "output": {"eligible": true, "met_criteria": ["Age between 0 and 120", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01083", "age": 65, "sex": "Female", "country": "United States", "bmi": 44.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03005", "age": 22, "sex": "Female", "country": "United States", "bmi": 41.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01056", "age": 29, "sex": "Male", "country": "United States", "bmi": 36.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01817", "age": 63, "sex": "Male", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01228", "age": 58, "sex": "Female", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01852", "age": 40, "sex": "Female", "country": "United States", "bmi": 32.6, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01686_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 44.0, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02229", "age": 14, "sex": "Female", "country": "United States", "bmi": 39.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01959_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 38.5, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03544", "age": 12, "sex": "Female", "country": "United States", "bmi": 43.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01002_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03088", "age": 14, "sex": "Male", "country": "United States", "bmi": 40.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03486_AGE", "age": 2, "sex": "Female", "country": "United States", "bmi": 31.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT03022682", "url": "https://clinicaltrials.gov/ct2/show/NCT03022682", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "Inclusion Criteria:-Participants will be healthy individuals between the ages of 18-75 years. Thesecutoffs are designed to allow inclusion of postmenopausal women, and younger/moreactive patients who are increasingly undergoing bariatric surgery.-Patients with either diabetes type 2 or the metabolic syndrome will be included inthe cohort.Exclusion Criteria:-Participants with chronic kidney disease (> stage 4)-Autoimmune/inflammatory disease (e.g., Lupus, Ulcerative Colitis, etc.)-Unstable angina, New York (NY) class III or IV congestive heart failure ormyocardial infarction within 3 months of entry-Clinically significant liver disease (e.g. Cirrhosis or liver failure)-Weight > 450 pounds (DXA scan weight limit)-History of organ transplant-Treatment with chemotherapy or radiation therapy at the time of enrollment in study.-Poorly controlled asthma (participants requiring inhaled glucocorticoids and/or oralglucocorticoids)-Current nasal corticosteroid use (within the past month)-Excessive alcohol or substance abuse-Current use of anabolic steroids or testosterone for bodybuilding purposes.Testosterone use is permitted if prescribed for hypogonadism and dose stable for thepast 6 months.-Patients actively enrolled in interventional trials involving investigational agents-Pregnant or breast-feeding women-Appears unlikely or unable to participate in the required study procedures asassessed by the investigator, study coordinator or designee.-History of abnormal clotting-Previous bariatric surgery-Anticoagulant use-Methadone medication", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02135_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 28.3, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01997_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01377_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01848_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 22.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00414", "age": 16, "sex": "Male", "country": "United States", "bmi": 20.4, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01628_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01359_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 43.7, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02892_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 39.8, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 15-18"], "rationale": "Failed criteria: Age not in range 15-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02574", "age": 33, "sex": "Male", "country": "United States", "bmi": 41.2, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 15-18"], "rationale": "Failed criteria: Age not in range 15-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00340_AGE", "age": 5, "sex": "Female", "country": "United States", "bmi": 37.8, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 15-18"], "rationale": "Failed criteria: Age not in range 15-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03384_BMI", "age": 22, "sex": "Male", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 15-18"], "rationale": "Failed criteria: Age not in range 15-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00472_AGE", "age": 10, "sex": "Female", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 15-18"], "rationale": "Failed criteria: Age not in range 15-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00775", "age": 56, "sex": "Male", "country": "United States", "bmi": 37.2, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT02132377", "url": "http://clinicaltrials.gov/show/NCT02132377", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-age 15-18-body mass index 85% percentile or higher for age/sex-weight stable 5 lbs in the the 3 months prior Exclusion Criteria:-use of medications affecting body weight, cholesterol, or blood pressure-dietary allergies-metabolic disorder-eating disorder-behavioral or psychological disorders-endocrine disorder (including type 1 diabetes)-asthma-anemia-use of investigational medications or devices (within past 4 weeks)-use of over the counter supplements that may effect study endpoints", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 15-18"], "rationale": "Failed criteria: Age not in range 15-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03564_AGE", "age": 11, "sex": "Male", "country": "United States", "bmi": 35.9, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 15", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01503_BMI", "age": 13, "sex": "Male", "country": "United States", "bmi": 18.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 15", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01562_AGE", "age": 13, "sex": "Female", "country": "United States", "bmi": 41.5, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 15", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01663", "age": 46, "sex": "Female", "country": "United States", "bmi": 42.7, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-15"], "rationale": "Failed criteria: Age not in range 8-15", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03350", "age": 42, "sex": "Female", "country": "United States", "bmi": 40.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-15"], "rationale": "Failed criteria: Age not in range 8-15", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02177_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 44.1, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-15"], "rationale": "Failed criteria: Age not in range 8-15", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01349", "age": 60, "sex": "Male", "country": "United States", "bmi": 33.4, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-15"], "rationale": "Failed criteria: Age not in range 8-15", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01008", "age": 25, "sex": "Male", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT02058342", "url": "http://clinicaltrials.gov/show/NCT02058342", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 15, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Having Prader-Willi Syndrome and being between ages 8-15 years. PWS status will be documented by appropriate molecular and cytogenetic testing (i.e., chromosomes, florescence in situ hybridization [FISH] 15, DNA methylation, DNA polymorphism studies)-Being obese and between ages 8-11 years. Obesity is defined as havinga body fat percentage greater than the 95th percentile (McCarthy, H. D., Cole, T. J., Fry, T., Jebb, S. A., & Prentice, A. M. (2006). Body fat reference curves for children. International Journal of Obesity (Lond), 30(4), 598-602). Exclusion Criteria:-Obese children without Prader-Willi Syndrome currently on lipid-lowering medication, diabetes medications, or blood pressure medications.-Being pregnant", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-15"], "rationale": "Failed criteria: Age not in range 8-15", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02142", "age": 26, "sex": "Female", "country": "United States", "bmi": 34.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00045", "age": 23, "sex": "Male", "country": "United States", "bmi": 42.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02545", "age": 31, "sex": "Male", "country": "United States", "bmi": 41.9, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02678", "age": 23, "sex": "Male", "country": "United States", "bmi": 37.8, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01584", "age": 55, "sex": "Female", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 120", "BMI between 30.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01486_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.0, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03288_AGE", "age": 12, "sex": "Male", "country": "United States", "bmi": 34.8, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03452", "age": 13, "sex": "Male", "country": "United States", "bmi": 34.6, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00863_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 43.9, "diagnoses": ["obesity", "diabetes"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02097_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 35.9, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02818_BMI", "age": 23, "sex": "Female", "country": "United States", "bmi": 22.5, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 18 and 120"], "failed_criteria": ["BMI not in range 30.0-100"], "rationale": "Failed criteria: BMI not in range 30.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02106", "age": 14, "sex": "Male", "country": "United States", "bmi": 30.5, "diagnoses": ["obesity", "depression"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03084", "age": 12, "sex": "Female", "country": "United States", "bmi": 42.2, "diagnoses": ["obesity", "diabetes"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03490", "age": 15, "sex": "Female", "country": "United States", "bmi": 38.0, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01983215", "url": "https://clinicaltrials.gov/show/NCT01983215", "status": "Recruiting", "countries": ["United States", "United States", "United States", "United States", "United States"], "age_min": 18, "age_max": null, "bmi_min": 30.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver ; Inclusion Criteria:-subjects over 18 years old-obese (BMI > 30) and or diabetic Exclusion Criteria:-current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to adhesive, sensitivity to silver", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 30.0 and 100"], "failed_criteria": ["Age not in range 18-120"], "rationale": "Failed criteria: Age not in range 18-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03031", "age": 22, "sex": "Female", "country": "United States", "bmi": 34.3, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 25", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02710", "age": 19, "sex": "Female", "country": "United States", "bmi": 31.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 25", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01237", "age": 21, "sex": "Male", "country": "United States", "bmi": 39.7, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 25", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00728_AGE", "age": 19, "sex": "Male", "country": "United States", "bmi": 44.9, "diagnoses": ["obesity", "hypertension"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 25", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01556", "age": 18, "sex": "Female", "country": "United States", "bmi": 40.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 25", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02646_AGE", "age": 21, "sex": "Male", "country": "United States", "bmi": 34.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 25", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01601", "age": 12, "sex": "Male", "country": "United States", "bmi": 35.1, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-25"], "rationale": "Failed criteria: Age not in range 18-25", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01402_AGE", "age": 1, "sex": "Female", "country": "United States", "bmi": 32.8, "diagnoses": ["obesity", "diabetes"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-25"], "rationale": "Failed criteria: Age not in range 18-25", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01009_BMI", "age": 38, "sex": "Female", "country": "United States", "bmi": 19.5, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-25"], "rationale": "Failed criteria: Age not in range 18-25", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00631", "age": 35, "sex": "Female", "country": "United States", "bmi": 36.2, "diagnoses": ["obesity", "hypertension"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-25"], "rationale": "Failed criteria: Age not in range 18-25", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03321_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.1, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-25"], "rationale": "Failed criteria: Age not in range 18-25", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00710_AGE", "age": 5, "sex": "Male", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-25"], "rationale": "Failed criteria: Age not in range 18-25", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00461_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 44.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01578512", "url": "http://clinicaltrials.gov/show/NCT01578512", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 25, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-18-25 years old-body mass index 25-45-willing to be randomly assigned to any of the 3 arms-available during the time frame of the study-willing to complete assessment visits at 0, 2, 4 and 6 months Exclusion Criteria:-Age or BMI outside of eligible range-Medical condition that would interfere with weight loss or make unsupervised physical activity unsafe-Pregnant or nursing within 6 months-recent weight loss >10% of body weight-History of eating disorder-Substance abuse or dependence", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 18-25"], "rationale": "Failed criteria: Age not in range 18-25", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01793", "age": 46, "sex": "Female", "country": "United States", "bmi": 40.8, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 18.5 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01617", "age": 39, "sex": "Female", "country": "United States", "bmi": 33.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 18.5 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01996", "age": 26, "sex": "Male", "country": "United States", "bmi": 32.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 18.5 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02009_AGE", "age": 19, "sex": "Male", "country": "United States", "bmi": 27.5, "diagnoses": ["obesity", "hypertension"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 18.5 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03350", "age": 42, "sex": "Female", "country": "United States", "bmi": 40.2, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 18 and 75", "BMI between 18.5 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01499_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 18.5 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01496_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 39.2, "diagnoses": ["obesity", "depression"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 18.5 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00681", "age": 11, "sex": "Female", "country": "United States", "bmi": 33.7, "diagnoses": ["obesity", "obesity"], "meds": ["liraglutide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 18.5 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03609", "age": 11, "sex": "Male", "country": "United States", "bmi": 31.3, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 18.5 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02475_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 40.1, "diagnoses": ["obesity", "obesity"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT01568671", "url": "https://clinicaltrials.gov/ct2/show/NCT01568671", "status": "Recruiting", "countries": ["United States"], "age_min": 18, "age_max": 75, "bmi_min": 18.5, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "-INCLUSION CRITERIA:-Generally healthy.-Males between the age greater than or equal to 18 -35 years or between 55-75 years,male orand females between the age 18-35 years.-Self-reported non-Hispanic and non-Latino Caucasian and African-Americans-Written informed consent.EXCLUSION CRITERIA:-Hypo- or hyper-thyroid (history or TSH >5.0<0.4 miU/L)-Psychological conditions,such as (but not limited to) claustrophobia, clinicaldepression, bipolar disorders, that would be incompatible with safe and successfulparticipation in this study-Weight change >5% in the past 6 months or a trained athleteBlood pressure greater than 140/90 mmHg or current antihypertensive therapy-History of cardiovascular disease-BMI <18.5, between 25.1-29.9, and >40 Kg/m(2)-Diabetes mellitus (fasting serum glucose > 126 mg/dL)-Liver disease or ALT serum level greater than two times the laboratory upper limitof normal-Iron deficiency (Ferritin < 30 mcg/L males, < 15 mcg/L females)-Abnormal kidney function (eGFR<60 ml/min/1.73m(2))-History of illicit drug or alcohol abuse within the last 5 years; current use ofdrugs (by history) or alcohol (CAGE greater than or equal to 2)-Current use of medications/dietary supplements/alternative therapies known to alterenergy metabolism-Pregnancy/breastfeeding/hormonal contraception or childbirth within the last year-Perimenopausal (as self-described within two years from onset of amenorrhea orcurrent complaints of hot flashes)-For pre-menopausal women, irregular periods or polycystic ovarian disease-Current smoker or user of tobacco products-Metal implant that prevents subject from being in a MRI scanner.All subjects will be fully informed of the aims, nature, and risks of the study prior togiving written informed consent.", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 18.5 and 100"], "failed_criteria": ["Age not in range 18-75"], "rationale": "Failed criteria: Age not in range 18-75", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00814", "age": 70, "sex": "Male", "country": "United States", "bmi": 42.6, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 120", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03499_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 35.5, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 120", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01614_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.3, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 120", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00637", "age": 50, "sex": "Male", "country": "United States", "bmi": 41.1, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 120", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02664", "age": 20, "sex": "Male", "country": "United States", "bmi": 38.1, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 15 and 120", "BMI between 35.0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02667", "age": 13, "sex": "Female", "country": "United States", "bmi": 37.1, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 35.0 and 100"], "failed_criteria": ["Age not in range 15-120"], "rationale": "Failed criteria: Age not in range 15-120", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00853", "age": 56, "sex": "Male", "country": "United States", "bmi": 33.8, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 15 and 120"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01168_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.6, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 15 and 120"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01956_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 32.2, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 15 and 120"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01228_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 32.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 15 and 120"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02250", "age": 54, "sex": "Female", "country": "United States", "bmi": 32.2, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 15 and 120"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01005", "age": 40, "sex": "Female", "country": "United States", "bmi": 34.7, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 15 and 120"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02008_BMI", "age": 60, "sex": "Female", "country": "United States", "bmi": 21.5, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT00358592", "url": "http://clinicaltrials.gov/show/NCT00358592", "status": "Recruiting", "countries": ["United States"], "age_min": 15, "age_max": null, "bmi_min": 35.0, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-pregnant women undergoing non-urgent cesarean delivery Exclusion Criteria:-women undergoing urgent cesarean delivery-BMI <35kg/m2-women undergoing vaginal delivery-positive urine drug screen or known history of methadone maintenance or substance abuse", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["Age between 15 and 120"], "failed_criteria": ["BMI not in range 35.0-100"], "rationale": "Failed criteria: BMI not in range 35.0-100", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02497_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 41.6, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00329_AGE", "age": 17, "sex": "Female", "country": "United States", "bmi": 38.4, "diagnoses": ["obesity", "diabetes"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02498_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 37.9, "diagnoses": ["obesity", "hypertension"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01013_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 42.8, "diagnoses": ["obesity", "obesity"], "meds": ["metformin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01289_AGE", "age": 17, "sex": "Male", "country": "United States", "bmi": 30.9, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P03474_BMI", "age": 12, "sex": "Female", "country": "United States", "bmi": 29.5, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "General Hospital", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": true, "met_criteria": ["Age between 8 and 18", "BMI between 0 and 100"], "failed_criteria": [], "rationale": "Meets all criteria.", "confidence": 0.8}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00710", "age": 7, "sex": "Male", "country": "United States", "bmi": 31.1, "diagnoses": ["obesity", "obesity"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 100}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-18"], "rationale": "Failed criteria: Age not in range 8-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02184_AGE", "age": 39, "sex": "Male", "country": "United States", "bmi": 40.9, "diagnoses": ["obesity", "diabetes"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 500}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-18"], "rationale": "Failed criteria: Age not in range 8-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01658_AGE", "age": 39, "sex": "Male", "country": "United States", "bmi": 34.0, "diagnoses": ["obesity", "depression"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-18"], "rationale": "Failed criteria: Age not in range 8-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00993", "age": 22, "sex": "Male", "country": "United States", "bmi": 42.8, "diagnoses": ["obesity", "hypertension"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-18"], "rationale": "Failed criteria: Age not in range 8-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P01071", "age": 59, "sex": "Female", "country": "United States", "bmi": 30.9, "diagnoses": ["obesity", "obesity"], "meds": [], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Private", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-18"], "rationale": "Failed criteria: Age not in range 8-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P00430", "age": 52, "sex": "Female", "country": "United States", "bmi": 39.9, "diagnoses": ["obesity", "depression"], "meds": ["tirzepatide"], "pregnant": false, "bariatric_surgery_history": false, "insurance": null, "site_affiliation": "FQHC-Missouri", "preferences": {"max_distance_km": 200}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-18"], "rationale": "Failed criteria: Age not in range 8-18", "confidence": 0.6}}
{"instruction": "Decide eligibility for the patient against the trial and explain.", "input": {"patient": {"id": "P02403", "age": 44, "sex": "Male", "country": "United States", "bmi": 44.8, "diagnoses": ["obesity", "depression"], "meds": ["insulin"], "pregnant": false, "bariatric_surgery_history": false, "insurance": "Medicaid", "site_affiliation": null, "preferences": {"max_distance_km": 50}}, "trial": {"trial_id": "NCT00000112", "url": "http://clinicaltrials.gov/show/NCT00000112", "status": "Recruiting", "countries": ["United States"], "age_min": 8, "age_max": 18, "bmi_min": null, "bmi_max": null, "requires_medicaid": false, "exclusions": [], "raw_inclusion": "<br> Inclusion Criteria:-Obesity: BM +/- 95% for age general good health", "raw_exclusion": ""}}, "output": {"eligible": false, "met_criteria": ["BMI between 0 and 100"], "failed_criteria": ["Age not in range 8-18"], "rationale": "Failed criteria: Age not in range 8-18", "confidence": 0.6}}
